Skip to Main Content
CWRU Links


2009 Member Publications

This is a list of publications authored by Cancer Center members. Cancer Center members are highlighted in BOLD text. 

Publications are listed in alphabetical order by first author. 

Abdallah P, Luciano P, Runge KW, Lisby M, Géli V, Gilson E, Teixeira MT. A two-step model for senescence triggered by a single critically short telomere. Nat Cell Biol 11:988-993, 2009.


Abouassaly R, Paciorek A, Ryan CJ, Carroll PR, Klein EA. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE. Cancer 115:4470-4476, 2009.


Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, Johnston E, Katzenstein D, Siddiqui A, Herrera C, Fischetti L, Shattock RJ, Arts EJ. CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. J Virol 83:5592-5605, 2009. PMCID: PMC2681953


Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA. Resistance to colistin in acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 53:3628-3634, 2009.


Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GM, Murthy SC, Mason DP, Rodriguez CP, Ives DI. Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol 4:1264-1269, 2009.


Adelstein DJ, Ridge JA, Gillison ML, Chaturvedi AK, D'Souza G, Gravitt PE, Westra W, Psyrri A, Martin Kast W, Koutsky LA, Giuliano A, Krosnick S, Trotti A, Schuller DE, Forastiere A, Dansky Ullmann C. Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck 31:1393-1422, 2009.


Advani AS, Hunger SP, Burnett AK. Acute leukemia in adolescents and young adults. Semin Oncol 36:213-226, 2009.


Advani A, Jin T, Bolwell B, Copelan E, Sekeres M, Sobecks R, Sungren S, Yurch M, Kalaycio M. A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse. Leuk Lymphoma 50:1126-1131, 2009.


Advani AS, Laughlin MJ. Umbilical cord blood transplantation for acute myeloid leukemia. Curr Opin Hematol 16:124-128, 2009.


Affronti ML, Heery CR, Herndon JE 2nd, Rich JN, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Bigner DD, Friedman HS. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. Cancer 115:3501-3511, 2009.


Aksoy P, Zhu MJ, Kalari KR, Moon I, Pelleymounter LL, Eckloff BW, Wieben ED, Yee VC, Weinshilboum RM, Wang L. Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics. Pharmacogenet Genomics 19:567-576, 2009.


Al-Ahmadi W, Al-Haj L, Al-Mohanna FA, Silverman RH, Khabar KS. RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth. Oncogene 28:1782-1791, 2009.


Ali MM, Liu G, Shah T, Flask CA, Pagel MD. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies. Acc Chem Res 42:915-924, 2009.


Aliev G, Liu J, Shenk JC, Fischbach K, Pacheco GJ, Chen SG, Obrenovich ME, Ward WF, Richardson AG, Smith MA, Gasimov E, Perry G, Ames BN. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. J Cell Mol Med 13:320-333, 2009.


Allen BC, Baker ME, Falk GW. Role of barium esophagography in evaluating dysphagia. Cleve Clin J Med 76:105-111, 2009.


Allende DS, Hansel DE, Maclennan GT. Ganglioneuroma of the adrenal gland. J Urol 182:714-715, 2009.


Almhanna K, Wongchaowart N, Sweetenham J. Intracerebral Hodgkin's lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma: a case report and literature review. Cancer Invest 27:215-220, 2009.


Alper O, Stetler-Stevenson WG, Harris LN, Leitner WW, Ozdemirli M, Hartmann D, Raffeld M, Abu-Asab M, Byers S, Zhuang Z, Oldfield EH, Tong Y, Bergmann-Leitner E, Criss WE, Nagasaki K, Mok SC, Cramer DW, Karaveli FS, Goldbach-Mansky R, Leo P, Stromberg K, Weil RJ. Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma. Cancer Sci 100:1748-1756, 2009.


Alsberg E, Rowley JA. Technologies for enhancing tissue engineering: materials and environments for guiding stem cell function. Preface. Tissue Eng Part A 15:203-204, 2009.


Amin MB, Maclennan GT, Gupta R, Grignon D, Paraf F, Vieillefond A, Paner GP, Stovsky M, Young AN, Srigley JR, Cheville JC. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 33:384-392, 2009.


Anand S, Honari G, Hasan T, Elson P, Maytin EV. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res 15:3333-3343, 2009.


Anderson PD, Lam MY, Poirier C, Bishop CE, Nadeau JH. The role of the mouse y chromosome on susceptibility to testicular germ cell tumors. Cancer Res 69:3614-3618, 2009.


Anderson PD, Nelson VR, Tesar PJNadeau JH. Genetic factors on mouse chromosome 18 affecting susceptibility to testicular germ cell tumors and permissiveness to embryonic stem cell derivation. Cancer Res 69:9112-9117, 2009.


Angel TE, Chance MR, Palczewski K. Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors. Proc Natl Acad Sci USA 106:8555-8560, 2009. PMCID: PMC2688986


Angel TE, Gupta S, Jastrzebska B, Palczewski K, Chance MR. Structural waters define a functional channel mediating activation of the GPCR, rhodopsin. Proc Natl Acad Sci U S A 106:14367-14372, 2009. PMCID: 2732891


Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GHPeereboom DM, Stevens G, McGregor J, Jahnke K, Lacy CA, Hedrick NA, Shalom E, Ference S, Bell S, Sorenson L, Tyson RM, Haluska M, Neuwelt EA. Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clin Oncol 27:3503-3509, 2009.


Annaberdyev S, Gibbons J, Hardacre JM. Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy. World J Surg Oncol 7:30, 2009. PMCID: PMC2661077


Apte SS. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily-functions and mechanisms. J Biol Chem 284:31493-31497, 2009. PMCID: PMC2797218


Arfons LM, Tomblyn M, Rocha V, Lazarus HM. Second hematopoietic stem cell transplantation in myeloid malignancies. Curr Opin Hematol 16:112-123, 2009. PMCID: PMC2768338


Arif A, Jia J, Mukhopadhyay R, Willard B, Kinter M, Fox PL. Two-site phosphorylation of EPRS coordinates multimodal regulation of noncanonical translational control activity. Mol Cell 35:164-180, 2009.


Armstrong AB, Wang M, Eble JN, MacLennan GT, Montironi R, Tan PH, Lopez-Beltran A, Zhang S, Baldridge LA, Spartz H, Cheng L. TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol 22:113-118, 2009.


Ataergin S, Ozet A, Solchaga L, Turan M, Beyzadeoglu M, Oysul K, Arpaci F, Komurcu S, Surenkok S, Ozturk M. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone. Med Oncol 26:276-286, 2009.


Ataergin S, Tasar M, Solchaga L, Ozet A, Arpaci F. Unusual severe complication following transarterial chemoembolization for metastatic malignant melanoma: giant intrahepatic cyst and fatal hepatic failure. Cardiovasc Intervent Radiol 32:361-364, 2009.


Ataergin SA, Kindwall-Keller TBerger NALazarus HM. New generation pharmacotherapy in elderly multiple myeloma patients. Expert Opin Pharmacother 10:81-98, 2009.


Atkins MB, Bukowski RM, Escudier BJ, Figlin RA, Hudes GH, Kaelin WG Jr, Linehan WM, McDermott DF, Mier JW, Pedrosa I, Rini BI, Signoretti S, Sosman JA, Teh BT, Wood CG, Zurita AJ, King L. Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. Cancer 115(10 Suppl):2247-2251, 2009.


Attaya S, Kanthi Y, Aster R, McCrae K. Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction. Platelets 20:64-67, 2009.


Auerbach MB, Shimoda N, Amano H, Rosenblum JM, Kish DD, Farber JM, Fairchild RL. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts. Am J Pathol 174:2172-2181, 2009. PMCID: PMC2684182


Auletta JJCooke KR. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease. Curr Opin Pediatr 21:30-38, 2009.


Aydin H, Magi-Galluzzi C, Lane BR, Sercia L, Lopez JI, Rini BI, Zhou M. Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol 33:289-297, 2009.

Baar JSilverman P, Lyons J, Fu P, Abdul-Karim F, Ziats N, Wasman J, Hartman P, Jesberger J, Dumadag L, Hohler E, Leeming R, Shenk R, Chen H,McCrae K, Dowlati A, Remick SC, Overmoyer B. A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers. Clin Cancer Res 15:3583-3590, 2009. PMCID: PMC2722840


Babel N, Brestrich G, Gondek LP, Sattler A, Wlodarski MW, Poliak N, Bethke N, Thiel A, Hammer MH, Reinke P, Maciejewski JP. Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes. J Am Soc Nephrol 20:344-352, 2009. PMCID: PMC2637041


Bagby CM, Maclennan GT. Extramammary Paget's disease of the penis and scrotum. J Urol 182:2908-2909, 2009.

Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C, Dehn J, Friedman D, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Loberiza F, Maharaj D, McCarthy P, Setterholm M, Spellman S, Trigg M, Maziarz RT, Switzer G, Lee SJ, Rizzo JD. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 15:1543-1554, 2009. PMCID: 2775819


Balasubramanian D, Scacheri PC. Functional studies of menin through genetic manipulation of the Men1 homolog in mice. Adv Exp Med Biol 668:105-115, 2009.


Balasubramanian P, Yang L, Lang JC, Jatana KR, Schuller D, Agrawal A, Zborowski M, Chalmers JJ. Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells. Mol Pharm 6:1402-1408, 2009.


Barami K, Sloan AE, Rojiani A, Schell MJ, Staller A, Brem S. Relationship of gliomas to the ventricular walls. J Clin Neurosci 16:195-201, 2009.


Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, Mackinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control. 20:1129-1138, 2009.


Barr PM, Creger RJ, Berger NA. Pharmacology of acute lymphoblastic leukemia therapy. In: Adult Acute Lymphocytic Leukemia: Biology and Treatment. Humana Press, 2009.


Barr PM, Fu P, Lazarus HM, Horvath N, Gerson SL, Koc ON, Bahlis NJ, Snell MR, Dowlati A, Cooper BW. Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma. Br J Haematol 147:89-96, 2009. PMCID: PMC2827854


Barr PM, Lazarus HM, Cooper BW, Schluchter MD, Panneerselvam A, Jacobberger JW, Hsu JW, Janakiraman N, Simic A, Dowlati A, Remick SC. Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant. Am J Hematol 84:484-487, 2009.


Basu A, Haldar S. 2-Methoxyestradiol mediated signaling network in pancreatic cancer. Front Biosci 14:2170-2180, 2009.


Basu A, Haldar S. Anti-proliferative and proapoptotic effects of benzyl isothiocyanate on human pancreatic cancer cells is linked to death receptor activation and RasGAP/Rac1 down-modulation. Int J Oncol 35:593-599, 2009.


Beach JR, Egelhoff TT. Myosin II recruitment during cytokinesis independent of centralspindlin-mediated phosphorylation. J Biol Chem 284:27377-27383, 2009.


Beck RC, Padival M, Yeh D, Ralston J, Cooke KR, Lowe JB. The Notch ligands Jagged2, Delta1, and Delta4 induce differentiation and expansion of functional human NK cells from CD34(+) cord blood hematopoietic progenitor cells. Biol Blood Marrow Transplant 15:1026-1037, 2009. PMCID: PMC2730186


Bednarz G, Machtay M, Werner-Wasik M, Downes B, Bogner J, Hyslop T, Galvin J, Evans J, Curran W Jr, Andrews D. Report on a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapy. Med Phys 36:12-17, 2009.


Beebe-Dimmer JL, Nock NL, Neslund-Dudas C, Rundle A, Bock CH, Tang D, Jankowski M, Rybicki BA. Racial differences in risk of prostate cancer associated with metabolic syndrome. Urology 74:185-190, 2009. PMCID: PMC2704922


Bekaii-Saab T, Markowitz J, Prescott N, Sadee W, Heerema N, Wei L, Dai Z, Papp A, Campbell A, Culler K, Balint C, O'Neil B, Lee RM, Zalupski M, Dancey J, Chen H, Grever M, Eng C, Villalona-Calero M. A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas. Clin Cancer Res 15:5895-5901, 2009.


Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao YL. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal, and vaginal self-collected specimens; implications for vaginal self-collection. Int J Cancer 9999:999A, 2009.


Belinson JL, Pretorius RG, Enerson C, Garcia F, Cruz EP, Belinson SE, Yeverino García E, Brainard J. The Mexican cervical cancer screening trial: self-sampling for human papillomavirus with unaided visual inspection as a secondary screen. Int J Gynecol Cancer 19:27-32, 2009.


Bennett BC, Wan Q, Ahmad MF, Langan P, Dealwis CG. X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design. J Struct Biol 166:162-171, 2009. PMCID: 2738603


Bennett KL, Lee W, Lamarre E, Zhang X, Seth R, Scharpf J, Hunt J, Eng C. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes Chromosomes Cancer 49:319-326, 2009.


Bennett KL, Romigh T, Eng C. Disruption of transforming growth factor-{beta} signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis. Cancer Res 69:9301-9305, 2009.


Bennett KL, Romigh T, Arab K, Teresi RE, Tada Y, Eng C, Plass C. Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma. Int J Cancer 124:1285-1292, 2009. PMCID: PMC2676424


Bennett KL, Romigh T, Eng C. AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma. PLoS One 4:e6931, 2009. PMCID: PMC2734430


Berdis AJ. Mechanisms of DNA polymerases. Chem Rev 109:2862-2879, 2009.


Berg JW, Mehlman MJ, Rubin DB, Kodish E. Making all the children above average: ethical and regulatory concerns for pediatricians in pediatric enhancement research. Clin Pediatr (Phila) 48:472-480, 2009.


Berglund RK, Stephenson AJ, Cronin AM, Vickers AJ, Eastham JA, Klein EA, Guillonneau BD. Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram. Urology 73:1098-1103, 2009. PMCID: PMC2834301


Berney DM, Gopalan A, Kudahetti S, Fisher G, Ambroisine L, Foster CS, Reuter V, Eastham J, Moller H, Kattan MW, Gerald W, Cooper C, Scardino P, Cuzick J. Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. Br J Cancer 100:888-893, 2009.


Bernstein HB, Wang G, Plasterer MC, Zack JA, Ramasastry P, Mumenthaler SM, Kitchen CM. CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function. Virology 387:59-66, 2009. PMCID: PMC2667870


Berry DC, Noy N. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor. Mol Cell Biol 29:3286-3296, 2009.


Betapudi V, Egelhoff TT. Roles of an unconventional protein kinase and myosin II in amoeba osmotic shock responses. Traffic 10:1773-1784, 2009.


Bhakta S, Flick SM, Cooney MM, Greskovich JF, Gilkeson RC, Remick SC, Ortiz J. Myocardial stunning following combined modality combretastatin-based chemotherapy: Two case reports and review of the literature. Clin Cardiol 32:E80-E84, 2009.


Bidros DS, Vogelbaum MA. Novel drug delivery strategies in neuro-oncology. Neurotherapeutics 6:539-546, 2009.


Bing Z, MacLennan GT. Renal epithelioid angiomyolipoma. J Urol 182:2468-2469, 2009.


Bing Z, Zhang P, Tomaszewski JE, Maclennan GT. Primary Ewing sarcoma/primitive neuroectodermal tumor of the kidney. J Urol 181:1341-1342, 2009.


Biswas S, Biswas K, Richmond A, Ko J, Ghosh S, Simmons M, Rayman P, Rini B, Gill I, Tannenbaum CS, Finke JH. Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction. J Immunol 183:5050-5058, 2009.


Bobiak SN, Zyzanski SJ, Ruhe MC, Carter CA, Ragan B, Flocke SA, Litaker D, Stange KC. Measuring practice capacity for change: A tool for guiding quality improvement in primary care settings. Qual Manag Health Care 18:278-284, 2009.


Bodo J, Durkin L, Hsi ED. Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology. J Histochem Cytochem 57:701-708, 2009. PMCID: PMC2699325


Boedeker CC, Erlic Z, Richard S, Kontny U, Gimenez-Roqueplo AP, Cascon A, Robledo M, de Campos JM, van Nederveen FH, de Krijger RR, Burnichon N, Gaal J, Walter MA, Reschke K, Wiech T, Weber J, Rückauer K, Plouin PF, Darrouzet V, Giraud S, Eng C, Neumann HP. Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 94:1938-1944, 2009. PMCID: PMC2690424


Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomized trials. Lancet 373:1532-1542, 2009.


Boutros J, Almasan A. Combining 2-deoxy-D-glucose with electron transport chain blockers: a double-edged sword. Cancer Biol Ther 8:1237-1238, 2009.


Bowman KF, Rose JH, Radziewicz RM, O'Toole EE, Berila RA. Family caregiver engagement in a coping and communication support intervention tailored to advanced cancer patients and families. Cancer Nurs 32:73-81, 2009.


Bravo HC, Lee KE, Klein BE, Klein R, Iyengar SK, Wahba G. Examining the relative influence of familial, genetic, and environmental covariate information in flexible risk models. Proc Natl Acad Sci U S A 106:8128-8133, 2009. PMCID: 2677979


Brell JM, Krishnamurthi SS, Javle M, Saltzman J, Wollner I, Pelley R, Dowlati A, Kantharaj BN, Schluchter MD, Rath L, Ivy SP, Remick SC. A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma. Cancer Chemother Pharmacol 63:851-857, 2009.


Brennan CW, Daly BJ. Patient acuity: a concept analysis. J Adv Nurs 65:1114-1126, 2009.


Brodbeck WG, Anderson JM. Giant cell formation and function. Curr Opin Hematol 16:53-57, 2009. PMCID: PMC2679387


Brufsky AM, Bosserman LD, Caradonna RR, Haley BB, Jones CM, Moore HC, Jin L, Warsi GM, Ericson SG, Perez EA. Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results. Clin Breast Cancer 9:77-85, 2009.


Buck MD, Atreja A, Brunker CP, Jain A, Suh TT, Palmer RM, Dorr DA, Harris CM, Wilcox AB. Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records. Am J Geriatr Pharmacother 7:84-92, 2009.


Budd GT. Let me do more than count the ways: What circulating tumor cells can tell us about the biology of cancer. Mol Pharm 6:1307-1310, 2009.


Buist DS, Chubak J, Prout M, Yood MU, Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol 27:4508-4514 2009. PMCID: 2754903


Bujold K, Rhainds D, Jossart C, Febbraio M, Marleau S, Ong H. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages. Cardiovasc Res 83:457-464, 2009.


Bukowski RM. Axitinib treatment in patients with cytokine-refractory metastatic renal cell cancer. Curr Oncol Rep 11:81-83, 2009.


Bukowski RM. Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. Cancer 115:2273-2281, 2009.


Bukowski RM. Targeted therapies: bevacizumab and interferon-alpha in metastatic renal-cell carcinoma. Nat Rev Clin Oncol 6:253-254, 2009.


Bukowski RM. Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm. Clin Genitourin Cancer 7:9-10, 2009.


Burden-Gulley SM, Gates TJ, Craig SE, Lou SF, Oblander SA, Howell S, Gupta M, Brady-Kalnay SM. Novel peptide mimetic small molecules of the HAV motif in N-cadherin inhibit N-cadherin-mediated neurite outgrowth and cell adhesion. Peptides 30:2380-2387, 2009.


Burdick MJ, Reddy CA, Ulchaker J, Angermeier K, Altman A, Chehade N, Mahadevan A, Kupelian PA, Klein EA, Ciezki JP. Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer. Int J Radiat Oncol Biol Phys 73:1439-1445, 2009.


Burgoyne AM, Palomo JM, Phillips-Mason PJ, Burden-Gulley SM, Major DL, Zaremba A, Robinson S, Sloan AE, Vogelbaum MA, Miller RH, Brady-Kalnay SM. PTPmu suppresses glioma cell migration and dispersal. Neuro Oncol 11:767-778, 2009. PMCID: PMC2802397


Burgoyne AM, Phillips-Mason PJ, Burden-Gulley SM, Robinson S, Sloan AE, Miller RH, Brady-Kalnay SM. Proteolytic cleavage of protein Tyrosine Phosphatase micro regulates glioblastoma cell migration. Cancer Res 69:6960-6968, 2009. PMCID: PMC2747800


Buscaglia JM, DiMaio CJ, Pollack MJ, Shin EJ, Harris MD, Richards R, Chak A, Kantsevoy SV, Jagannath SB, Okolo PI 3rd. Are large side holes associated with reduced rates of pancreatic stent occlusion? Results of a prospective study. JOP 10:496-500, 2009.

Caloglu M, Ciezki J. Prostate-specific antigen bounce after prostate brachytherapy: review of a confusing phenomenon. Urology 74:1183-1190, 2009.


Camouse MM, Domingo DS, Swain FR, Conrad EP, Matsui MS, Maes D, Declercq L, Cooper KD, Stevens SR, Baron ED. Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Exp Dermatol 18:522-526, 2009.


Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG. Guideline for management of the clinical T1 renal mass. J Urol 182:1271-1279, 2009.


Chak A, Falk G, Grady WM, Kinnard M, Elston R, Mittal S, King JF, Willis JE, Kondru A, Brock W, Barnholtz-Sloan J. Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol 104:1913-1921, 2009.


Chak A. EUS and natural orifice transluminal endoscopic surgery. Gastrointest Endosc 69(Suppl 1):S210-S211, 2009. PMCID: PMC2648852


Chak A. What is the evidence for EUS-guided celiac plexus block/neurolysis? Gastrointest Endosc 69(Suppl 1):S172-S173, 2009. PMCID: PMC2657954


Chan E, Patel A, Heston W, Larchian W. Mouse orthotopic models for bladder cancer research. BJU Int 104:1286-1291, 2009.


Chan ER, Lavender H, Li G, Haviernik P, Bunting KD, Adams MD. An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominance. Exp Hematol 37:276-284, 2009. PMCID: PMC2656350


Chan ES, Patel AR, Smith AK, Klein JB, Thomas AA, Heston WD, Larchian WA. Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model. J Urol 182:2926-2931, 2009.


Chang DT, Colton E, Anderson JM. Paracrine and juxtacrine lymphocyte enhancement of adherent macrophage and foreign body giant cell activation. J Biomed Mater Res A 89:490-498, 2009.


Chang DT, Colton E, Matsuda T, Anderson JM. Lymphocyte adhesion and interactions with biomaterial adherent macrophages and foreign body giant cells. J Biomed Mater Res A 91:1210-1220, 2009.


Chaudhury A, Howe PH. The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma. IUBMB Life 61:929-39, 2009.


Chegary M, Brinke HT, Ruiter JP, Wijburg FA, Stoll MS, Minkler PE, van Weeghel M, Schulz H, Hoppel CL, Wanders RJ, Houten SM. Mitochondrial long chain fatty acid beta-oxidation in man and mouse. Biochim Biophys Acta 1791:806-815, 2009.


Chen BR, Runge KW. A new schizosaccharomyces pombe chronological lifespan assay reveals that caloric restriction promotes efficient cell cycle exit and extends longevity. Exp Gerontol 44:493-502, 2009.


Chen D, Lin Q, Box N, Roop D, Ishii S, Matsuzaki K, Fang T, Hornyak TJ, Reed JA, Stavnezer E, Timchenko NA, Medrano EE. SKI knockdown inhibits human melanoma tumor growth in vivo. Pigment Cell Melanoma Res 22:761-772, 2009.


Chen JH, Gong B, Bevilacqua PC, Carey PR, Golden BL. A catalytic metal ion interacts with the cleavage site G.U wobble in the HDV ribozyme. Biochemistry 48:1498-1507, 2009. PMCID: PMC2645270


Chen Q, Zhang T, Roshetsky JF, Ouyang Z, Essers J, Fan C, Wang Q, Hinek A, Plow EF, Dicorleto PE. Fibulin-4 regulates the expression of the tropoelastin gene and consequent elastic fiber formation by human fibroblasts. Biochem J 423:79-89, 2009.


Chen X, Saidel GM. Mathematical modeling of thermal ablation in tissue surrounding a large vessel. J Biomech Eng 131:011001, 2009.


Chen Y, Carlson EC, Chen ZY, Hamik A, Jain MK, Dunwoodie SL, Yang YC. Conditional deletion of Cited2 results in defective corneal epithelial morphogenesis and maintenance. Dev Biol 334:243-252, 2009. PMCID: PMC2752849


Cheng E, Elliott B, Ozsoyoglu ZM. Efficient computation of kinship and identity coefficients on large pedigrees. J Bioinform Comput Biol 7:429-453, 2009.


Cheng L, Zhang S, Davidson DD, MacLennan GT, Koch MO, Montironi R, Lopez-Beltran A. Molecular determinants of tumor recurrence in the urinary bladder. Future Oncol 5:843-857, 2009.


Cheng L, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol. 40:10-29, 2009.


Cheng W, MacLennan GT, Lavertu P, Wasman JK. Giant intrathyroid parathyroid adenoma: a preoperative and intraoperative diagnostic challenge. Ear Nose Throat J 88:E1-E3, 2009.


Cheng X, Kao HY. G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation. J Biol Chem 284:36395-36404, 2009. PMCID: PMC2794755


Cheon H, Stark GR. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci USA 106:9373-9378, 2009. PMCID: PMC2688000


Cho DC, Puzanov I, Regan MM, Schwarzberg T, Seery V, Lee MY, Liu V, Bhatt R, Koon H, Mier JW, Sosman JA, Atkins MB, McDermott DF. Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma. J Immunother 32:181-185, 2009.


Choi CM, Schmaier AH, Snell MR, Lazarus HM. Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment. Drugs 69:183-198, 2009.


Christie NM, Willer DO, Lobritz MA, Chan JK, Arts EJ, Ostrowski MA, Cochrane A, Luscher MA, MacDonald KS. Viral fitness implications of variation within an immunodominant CD8+ T-cell epitope of HIV-1. Virology 388:137-146, 2009.


Cianciola NL, Carlin CR. Adenovirus RID-{alpha} activates an autonomous cholesterol regulatory mechanism that rescues defects linked to Niemann-Pick disease type C. J Cell Biol 187:537-552, 2009. PMCID: PMC2779231


Ciezki JP. Brachytherapy for localized prostate cancer. Urology 73:473-475, 2009.


Ciezki JP, Klein EA. Brachytherapy or surgery? A composite view. Oncology (Williston Park) 23:960-964, 2009.


Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW,Meropol NJ. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 20:1223-1239, 2009.


Coleman JF, Hansel DE. Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder. Adv Anat Pathol 16:67-78, 2009.


Collichio FA, Kayoumi KM, Hande KR, Hawkins RE, Hawley JL, Adelstein DJ, D'Angelo JM, Stewart JA. Developing an in-training examination for fellows: the experience of the American Society of Clinical Oncology. J Clin Oncol 27:1706-1711, 2009.


Conry SJ, Milkovich KA, Yonkers NL, Rodriguez B, Bernstein HB, Asaad R, Heinzel FP, Tary-Lehmann M, Lederman MM, Anthony DD. Impaired PDC-NK activity in viremic HIV infection attributable to impairments in both PDC and NK function. J Virol 83:11175-11187, 2009. PMCID: 2772797.


Cook MS, Coveney D, Batchvarov I, Nadeau JH, Capel B. BAX-mediated cell death affects early germ cell loss and incidence of testicular teratomas in Dnd1(Ter/Ter) mice. Dev Biol 328:377-383, 2009. PMCID: 2689365


Cooper GS, Chak A. Response to rubenstein and inadomi. Am J Gastroenterol 104:3107-3108, 2009.


Cooper GS, Kou TD, Chak A. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol 104:1356-1362, 2009.


Cooper GS, Kou TD, Wong RC. Outpatient management of nonvariceal upper gastrointestinal hemorrhage: unexpected mortality in Medicare beneficiaries. Gastroenterology 136:108-114, 2009.


Copelan EA, Crilley PA, Szer J, Dodds AJ, Stevenson D, Phillips G, Elder P, Nivison-Smith I, Avalos BR, Penza S, Topolsky D, Sobecks R, Kalaycio M, Bolwell BJ. Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 15:851-855, 2009.


Copelan E, Pohlman B, Rybicki L, Kalaycio M, Sobecks R, Andresen S, Dean R, Koo A, Chan J, Sweetenham J, Bolwell B. A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma. Bone Marrow Transplant 43:101-105, 2009.

Dabir S, Kluge A, Dowlati A. The association and nuclear translocation of the PIAS3-STAT3 complex Is ligand and time dependent. Mol Cancer Res 7:1854-1860, 2009. PMCID: PMC2783234


Daly BJ, Douglas SL, Gordon NH, Kelley CG, O'Toole E, Montenegro H, Higgins P. Composite outcomes of chronically critically ill patients 4 months after hospital discharge. Am J Crit Care 18:456-464, 2009.


Daly BJ, Douglas S, Lipson A, Foley H. Needs of older caregivers of patients with advanced cancer. J Am Geriatr Soc 57 Suppl 2:S293-295, 2009.


Das A, Ngamruengphong S, Nagendra S, Chak A. Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management. Gastrointest Endosc 70:690-699.e6, 2009.


Das GK, Chan PP, Teo A, Loo JS, Anderson JM, Tan TT. In vitro cytotoxicity evaluation of biomedical nanoparticles and their extracts. J Biomed Mater Res A, 2009.


Das R, Burke T, Van Wagoner DR, Plow EF. L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages. Circ Res 105:167-175, 2009.


Dasarathy S, Kasumov T, Edmison JM, Gruca LL, Bennett C, Duenas C, Marczewski S, McCullough AJ, Hanson RW, Kalhan SC. Glycine and urea kinetics in non-alcoholic steatohepatitis in human: effect of intralipid infusion. Am J Physiol Gastrointest Liver Physiol 297:G567-575, 2009.


Dasgupta A, Raychaudhuri B, Haqqi T, Prayson R, Van Meir EG, Vogelbaum M, Haque SJ. Stat3 activation is required for the growth of U87 cell-derived tumours in mice. Eur J Cancer 45:677-684, 2009.


Davidson A, Leeper TC, Athanassiou Z, Patora-Komisarska K, Karn J, Robinson JA, Varani G. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein. Proc Natl Acad Sci U S A 106:11931-11936, 2009. PMCID: PMC2715490


Davis MP. Does palliative sedation always relieve symptoms? J Palliat Med 12:875-877, 2009.


Davis MP, Payne S. Nursing care, documentation and discourse. Progress in Palliative Care 17:109-110, 2009.


Davis MP, Yavuzsen T, Khoshknabi D, Kirkova J, Walsh D, Lasheen W, Lagman R, Karafa MT. Bioelectrical impedance phase angle changes during hydration and prognosis in advanced cancer. Am J Hosp Palliat Care 26:180-187, 2009.


Davis MP, Yavuzsen T, Kirkova J, Walsh D, Karafa M, LeGrand S, Lagman R. Validation of a simplified anorexia questionnaire. J Pain Symptom Manage 38:691-697, 2009.


De S, Cipriano R, Jackson MW, Stark GR. Overexpression of kinesins mediates docetaxel resistance in breast cancer cells. Cancer Res 69:8035-8042, 2009.


Deimling GT, Arendt JA, Kypriotakis G, Bowman KF. Functioning of older, long-term cancer survivors: the role of cancer and comorbidities. J Am Geriatr Soc 57 Suppl 2:S289-292, 2009.


Del Campo M, Mohr S, Jiang Y, Jia H, Jankowsky E, Lambowitz AM. Unwinding by local strand separation is critical for the function of DEAD-box proteins as RNA chaperones. J Mol Biol 389:674-693, 2009.


Demko CA, Sawyer D, Slivka M, Smith D, Wotman S. Prevalence of oral lesions in the dental office. Gen Dent 57:504-509, 2009.


Deng S, Zhang GF, Kasumov T, Roe CR, Brunengraber H. Interrelations between C4-ketogenesis, C5-ketogenesis and anaplerosis in the perfused rat liver. J Biol Chem 284:27799-27807 2009.


Denlinger C, Blanchard R, Xu L, Bernaards C, Litwin S, Spittle C, Berg D, McLaughlin S, Redlinger M, Dorr A, Hambleton J, Holden S, Kearns A, Kenkare-Mitra S, Lum B, Meropol NJ, O'Dwyer P. Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors. Cancer Chemother Pharmacol 65:97-105, 2009. PMCID: 2746259


Derakhshan JJ, Griswold MA, Sunshine JL, Duerk JL. Halting the effects of flow enhancement with effective intermittent zeugmatographic encoding (HEFEWEIZEN) in SSFP. J Magn Reson Imaging 29:1163-1174, 2009.


Devetten MP, Hari PN, Carreras J, Logan BR, van Besien K, Bredeson CN, Freytes CO, Gale RP, Gibson J, Giralt SA, Goldstein SC, Gupta V, Marks DI, Maziarz RT, Vose JM, Lazarus HM, Anderlini P. Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Biol Blood Marrow Transplant 15:109-117, 2009.


Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 15:2377-2392, 2009.


Dietrich RC, Padgett RA, Shukla GC. The conserved 3' end domain of U6atac snRNA can direct U6 snRNA to the minor spliceosome. RNA 15:1198-1207, 2009. PMCID: PMC2685526


Dipersio JF, Micallef IN, Stiff PJ, Bolwell BJ, Maziarz RT, Jacobsen E, Nademanee A, McCarty J, Bridger G, Calandra G. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with Non-Hodgkin's Lymphoma. J Clin Oncol 27:4767-4773, 2009.


Do JS, Min B. Differential requirements of MHC and of DCs for endogenous proliferation of different T-cell subsets in vivo. Proc Natl Acad Sci U S A 106:20394-20398, 2009. PMCID: PMC2787171


Do JS, Min B. IL-15 produced and trans-presented by DCs underlies homeostatic competition between CD8 and gamma-delta T cells in vivo. Blood 113:6361-6371, 2009.


Dotan E, Cohen SJ, Alpaugh KR, Meropol NJ. Circulating tumor cells: Evolving evidence and future challenges. Oncologist 14:1070-1082, 2009.


Douglas SL, Daly BJ, O'Toole EE, Kelley CG, Montenegro H. Age differences in survival outcomes and resource use for chronically critically ill patients. J Crit Care 24:302-310, 2009.


Dowlati A. Controversies in multi-institutional phase I clinical trials. Clin Adv Hematol Oncol 7:518-620, 2009.


Dowlati A, Posey J, Ramanathan RK, Rath L, Fu P, Chak A, Krishnamurthi S, Brell J, Ingalls S, Hoppel CL, Ivy P, Remick SC. Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers. Cancer Chemother Pharmacol 65:73-78, 2009.


Dreicer R. Conservative management of localised prostate cancer. Medicine Today 10:70, 2009.


Dreicer R. Second-line chemotherapy for advanced urothelial cancer: Because we should or because we can? J Clin Oncol 27:4444-4445, 2009.


Dreicer R, Li H, Stein M, Dipaola R, Eleff M, Roth BJ, Wilding G. Phase 2 trial of sorafenib in patients with advanced urothelial cancer: a Trial of the Eastern Cooperative Oncology Group. Cancer 115:4090-4095, 2009.


Dreicer R, Stadler WM, Ahmann FR, Whiteside T, Bizouarne N, Acres B, Limacher JM, Squiban P, Pantuck A. MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure. Invest New Drugs 27:379-386, 2009.


Dudley DM, Gao Y, Nelson KN, Henry KR, Nankya I, Gibson RM, Arts EJ. A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates. Biotechniques 46:458-467, 2009.


Dudley DM, Wentzel JL, Lalonde MS, Veazey RS, Arts EJ. Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques. J Virol 83:5067-5076, 2009. PMCID: PMC2682063


Dumot JA, Vargo JJ 2nd, Falk GW, Frey L, Lopez R, Rice TW. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc 70:635-644, 2009.


Duong HK, Sekeres MA. Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin. Clin Interv Aging 4:197-205, 2009. PMCID: PMC2685241

Eggener SE, Mueller A, Berglund RK, Ayyathurai R, Soloway C, Soloway MS, Abouassaly R, Klein EA, Jones SJ, Zappavigna C, Goldenberg L, Scardino PT, Eastham JA, Guillonneau B. A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol 181:1635-1641, 2009.


Ellis MJ, Gao F, Dehdashti F, Jeffe DB, Marcom PK, Carey LA, Dickler MN, Silverman P, Fleming GF, Kommareddy A, Jamalabadi-Majidi S, Crowder R, Siegel BA. Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study. JAMA 302:774-780, 2009.


Elmunzer BJ, Schomisch SJ, Trunzo JA, Poulose BK, Delaney CP, McGee MF, Faulx AL, Marks JM, Ponsky JL, Chak A. EUS in localizing safe alternate access sites for natural orifice transluminal endoscopic surgery: initial experience in a porcine model. Gastrointest Endosc 69:108-114, 2009.


Eng C, Leone G, Orloff MS, Ostrowski MC. Genomic alterations in tumor stroma. Cancer Res 69:6759-6764, 2009.


Erlic Z, Rybicki L, Peczkowska M, Golcher H, Kann PH, Brauckhoff M, Müssig K, Muresan M, Schäffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plöckinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz MK, Eng C, Neumann HP; European-American Pheochromocytoma Study Group. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clin Cancer Res 15:6378-6385, 2009.


Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Staehler M, Negrier S, Chevreau C, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Anderson S, Hofilena G, Shan M, Pena C, Lathia C, Bukowski RM. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol 27:3312-3318, 2009.


Escudier B, Szczylik C, Hutson TE, Demkow T, Staehler M, Rolland F, Negrier S, Laferriere N, Scheuring UJ, Cella D, Shah S, Bukowski RM. Randomized phase II trial of first-line treatment with sorafenib versus interferon alfa-2a in patients with metastatic renal cell carcinoma. J Clin Oncol 27:1280-1289, 2009.


Eskicorapci SY, Türkeri LB, Karabulut EC, Cal CD, Akpinar HE, Baltaci SF, Baykal KG, Turkish Validation Study Group of Kattan Preoperative Nomogram,Kattan MW, Ozen HI. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: A multicenter study of the uro-oncology society. Urology 74:1289-1295, 2009.


Expert Panel on Radiation Oncology–Brain Metastases, Videtic GM, Gaspar LE, Aref AM, Germano IM, Goldsmith BJ, Imperato JP, Marcus KJ, McDermott MW, McDonald MW, Patchell RA, Robins HI, Rogers CL, Suh JH, Wolfson AH, Wippold FJ 2nd. American College of Radiology appropriateness criteria on multiple brain metastases. Int J Radiat Oncol Biol Phys 75:961-965, 2009.

Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 114:121-127, 2009.


Fader AN, Drake RD, O'Malley DM, Gibbons HE, Huh WK, Havrilesky LJ, Gehrig PA, Tuller E, Axtell AE, Zanotti KM. For the Uterine Papillary Serous Carcinoma (UPSC) Consortium. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer 115:2119-2127, 2009.


Fader AN, Michener CM, Frasure HE, Giannios N, Belinson JL, Zanotti KM. Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer: surgical and survival outcomes. J Minim Invasive Gynecol 16:333-339, 2009.


Fader AN, Nagel C, Axtell AE, Zanotti KM, Kelley JL, Moore KN, Secord AA, Walsh CS, Huh WK, Gehrig PA, Gibbons H, Rose PG, Havrilesky LJ, Tuller E, Drake RD, Bottsford-Miller J, O'Malley DM; UPSC Consortium. Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. Gynecol Oncol 112:558-562, 2009.


Fader AN, Rose PG. Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to Paclitaxel. Int J Gynecol Cancer 19:1281-1283, 2009.


Fader AN, Starks D, Gehrig PA, Secord AA, Frasure HE, O'Malley DM, Tuller ER, Rose PG, Havrilesky LJ, Moore KN, Huh WK, Axtell AE, Kelley JL, Zanotti KM. UPSC Consortium. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma. Gynecol Oncol 115:244-248, 2009.


Falk GW. Autofluorescence endoscopy. Gastrointest Endosc Clin N Am 19:209-220, 2009.


Falk GW. Radiofrequency ablation of Barrett's esophagus: should everybody get it? Gastroenterology 136:2399-2402, 2009.


Falk GW. Risk factors for esophageal cancer development. Surg Oncol Clin N Am 18:469-485, 2009.


Fan C, Chen Q, Wang QK. Functional role of transcriptional factor TBX5 in Pre-mRNA splicing and Holt-Oram syndrome via association with SC35. J Biol Chem 284:25653-25663, 2009.


Fan C, Ouyang P, Timur AA, He P, You SA, Hu Y, Ke T, David DJ, Chen Q, Wang QK. Novel roles of gata1 in regulation of angiogenic factor AGGF1 and endothelial cell function. J Biol Chem 284:23331-2334 3, 2009.


Fan K, Borden E, Yi T. Interferon-gamma is induced in human peripheral blood immune cells in vitro by SSG/IL-2 and mediates its antitumor activity in vivo. J Interferon Cytokine Res 29:451-460, 2009.


Fan Y, Gong Y, Ghosh PK, Graham LM, Fox PL. Spatial coordination of actin polymerization and ILK-Akt2 activity during endothelial cell migration. Dev Cell 16:661-674, 2009. PMCID: PMC2692108


Farley J, Fuchiuji S, Darcy KM, Tian C, Hoskins WJ, McGuire WP, Hanjani P, Warshal D, Greer BE, Belinson J, Birrer MJ. Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study. Gynecol Oncol 113:341-347, 2009.


Feng Q, Abraham J, Feng T, Song Y, Elston RC, Zhu X. A method to correct for population structure using a segregation model. BMC Proc 3 Suppl 7:S104, 2009. PMCID: PMC2795875


Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM. Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biol Blood Marrow Transplant 15:1455-1464, 2009.


Fergany AF, Dhar N, Budd GT, Skacel M, Garcia JA. Primary extraosseous Ewing sarcoma of the kidney with level III inferior vena cava thrombus. Clin Genitourin Cancer 7:E95-E97, 2009.


Fernandez CV, Gao J, Strahlendorf C, Moghrabi A, Pentz RD, Barfield RC, Baker JN, Santor D, Weijer C, Kodish E. Providing research results to participants: attitudes and needs of adolescents and parents of children with cancer. J Clin Oncol 27:878-883, 2009. PMCID: PMC2668636


Fernandez HF, Sun Z, Yao X, Litzow MR, Luger SM, Paietta EM, Racevskis J, Dewald GW, Ketterling RP, Bennett JM, Rowe JM, Lazarus HM, Tallman MS. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med 361:1249-1259, 2009.


Ficarra V, Novara G, Boscolo-Berto R, Artibani W, Kattan MW. How accurate are present risk group assignment tools in penile cancer? World J Urol 27:155-160, 2009.


Fidias P, Pennell NA, Boral AL, Shapiro GI, Skarin AT, Eder JP Jr, Kwoh TJ, Geary RS, Johnson BE, Lynch TJ, Supko JG. Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancer. J Thorac Oncol 4:1156-1162, 2009.


Fielding AK, Rowe JM, Richards SM, Buck G, Moorman AV, Durrant IJ, Marks DI, McMillan AK, Litzow MR, Lazarus HM, Foroni L, Dewald G, Franklin IM, Luger SM, Paietta E, Wiernik PH, Tallman MS, Goldstone AH. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. Blood 113:4489-4496, 2009.


Fiocchi C. Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand? Dig Dis 27:226-235, 2009.


Fitzgerald S, Maclennan GT. Paratesticular liposarcoma. J Urol 181:331-332, 2009.


Fleming GM, Salama NN, Eid SK, Cooke KR, Mueller BA. Etanercept clearance during an in vitro model of continuous venovenous hemofiltration. Blood Purif 28:348-353, 2009.


Fleming ND, Alvarez-Secord A, Von Gruenigen V, Miller MJ, Abernethy AP. Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review. J Pain Symptom Manage 38:341-349, 2009.


Flocke SA, Kelly R, Highland J. Initiation of health behavior discussions during primary care outpatient visits. Patient Educ Couns 75:214-219, 2009.


Fong L, Kwek SS, O'Brien S, Kavanagh B, McNeel DG, Weinberg V, Lin AM, Rosenberg J, Ryan CJ, Rini BI, Small EJ. Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF. Cancer Res 69:609-615, 2009.


Foster LW, McLellan L, Rybicki L, Dabney J, Visnosky M, Bolwell B. Utility of the psychosocial assessment of candidates for transplantation (PACT) scale in allogeneic BMT. Bone Marrow Transplant 44:375-380, 2009.


Foster LW, McLellan L, Rybicki L, Tyler T, Bolwell BJ. Ethical reasoning about patient eligibility in allogeneic BMT based on psychosocial criteria. Bone Marrow Transplant 44:607-612, 2009.


Francis SA, Lam WK, Cance JD, Hogan VK. What's the 411? Assessing the feasibility of providing African American adolescents with HIV/AIDS prevention education in a faith-based setting. J Relig Health 48:164-177, 2009.


Francis SA, Liverpool J. A review of faith-based HIV prevention programs. J Relig Health 48:6-15, 2009.


Franko JL, Levine AD. Antigen-independent adhesion and cell spreading by inducible costimulator engagement inhibits T cell migration in a PI-3K-dependent manner. J Leukoc Biol 85:526-538, 2009. PMCID: PMC2653947


Freytes CO, Lazarus HM. Second hematopoietic SCT for lymphoma patients who relapse after autotransplantation: another autograft or switch to allograft? Bone Marrow Transplant 44:559-569, 2009.


Frias-Kletecka MC, Maclennan GT. Benign soft tissue tumors of the testis. J Urol 182:312-313, 2009.


Frisa PS, Jacobberger JW. Cell cycle-related cyclin b1 quantification. PLoS One 4:e7064, 2009. PMCID: PMC2740871


Fu H, Cai J, Clevers H, Fast E, Gray S, Greenberg R, Jain MK, Ma Q, Qiu M, Rowitch DH, Taylor CM, Stiles CD. A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development. J Neurosci 29:11399-11408, 2009.


Fu P, Dowlati A, Schluchter M. Comparison of power between randomized discontinuation design and upfront randomization design on progression-free survival. J Clin Oncol 27:4135-4141, 2009. PMCID: 2734425


Fu W, McCormick T, Qi X, Luo L, Zhou L, Li X, Wang BC, Gibbons HE, Abdul-Karim FW, Gorodeski GI. Activation of P2X(7)-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice. BMC Cancer 9:114, 2009. PMCID: PMC2676299


Fuchsjäger MH, Shukla-Dave A, Hricak H, Wang L, Touijer K, Donohue JF, Eastham JA, Kattan MW. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy. BJU Int 104:315-320, 2009.


Fukuzawa N, Schenk AD, Petro M, Nonomura K, Baldwin WM 3rd, Fairchild RL. High renal ischemia temperature increases neutrophil chemoattractant production and tissue injury during reperfusion without an identifiable role for CD4 T cells in the injury. Transpl Immunol 22:62-71., 2009.

Gale RP, Eapen M, Logan B, Zhang MJ, Lazarus HM. Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? Bone Marrow Transplant 43:435-446, 2009.


Gallogly MM, Starke DW, Mieyal JJ. Mechanistic and kinetic details of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation. Antioxid Redox Signal 1:1059-1081, 2009.


Gama V, Gomez JA, Mayo LD, Jackson MW, Danielpour D, Song K, Haas AL, Laughlin MJ, Matsuyama S. Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization. Cell Death Differ 16:758-769, 2009. PMCID: PMC2669846


Gao Y, Nankya I, Abraha A, Troyer RM, Nelson KN, Rubio A, Arts EJ. Calculating HIV-1 infectious titre using a virtual TCID(50) method. Methods Mol Biol 485:27-35, 2009.


Garcia JA, Cowey CL, Godley PA. Renal cell carcinoma. Curr Opin Oncol 21:266-271, 2009.


Gardberg A, Dice L, Pridgen K, Ko J, Patterson P, Ou S, Wetzel R, Dealwis C. Structures of Abeta-related peptide--monoclonal antibody complexes. Biochemistry 48:5210-5217, 2009. PMCID: 2720063


Gargesha M, Jenkins MW, Wilson DL, Rollins AM. High temporal resolution OCT using image-based retrospective gating. Opt Express 17:10786-10799, 2009. PMCID: 2748662


Gargesha M, Qutaish M, Roy D, Steyer G, Bartsch H, Wilson DL. Enhanced volume rendering techniques for high-resolution color cryo-imaging data. Proc Soc Photo Opt Instrum Eng 7262:72655V, 2009. PMCID: PMC2709868


George S, Bukowski RM. Role of everolimus in the treatment of renal cell carcinoma. Ther Clin Risk Manag 5:699-706, 2009. PMCID: PMC2747388


Gibson SE, Hsi ED. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol 40:653-661, 2009.


Gilligan T. The new data on prostate cancer screening: what should we do now? Cleve Clin J Med 76:446-448, 2009.


Goksedef BP, Kunos C, Belinson JL, Rose PG. Concurrent cisplatin-based chemoradiation International Federation of Gynecology and Obstetrics stage IB2 cervical carcinoma. Am J Obstet Gynecol 200:175.e1-e5, 2009.


Goldberg RM, Meropol NJ, Tabernero J. Accomplishments in 2008 in the treatment of advanced metastatic colorectal cancer. Gastrointest Cancer Res 3(5 Supp 2):S23-27, 2009. PMCID: PMC2791393


Golshayan AR, George S, Heng DY, Elson P, Wood LS, Mekhail TMGarcia JA, Aydin H, Zhou M, Bukowski RM, Rini BI. Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. J Clin Oncol 27:235-241, 2009.


Gomez JA, Sun W, Gama V, Hajkova D, Yoshida T, Wu Z, Miyagi M, Pink JJ, Jackson MW, Danielpour D, Matsuyama S. The C-terminus of interferon gamma receptor beta chain (IFNgammaR2) has antiapoptotic activity as a Bax inhibitor. Cancer Biol Ther 8:1771-1786, 2009.


Gong B, Chen JH, Bevilacqua PC, Golden BL, Carey PR. Competition between Co(NH3)63+ and inner sphere Mg2+ Ions in the HDV ribozyme. Biochemistry 48:11961-11970, 2009. PMCID: PMC2795014


Gong B, Chen JH, Yajima R, Chen Y, Chase E, Chadalavada DM, Golden BL, Carey PR, Bevilacqua PC. Raman crystallography of RNA. Methods 49:101-11PMCID: PMC2753759


Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 183:3170-3176, 2009.


Gorodeski GI. P2X7-mediated chemoprevention of epithelial cancers. Expert Opin Ther Targets 13:1313-1332, 2009.


Goss E, Lopez AM, Brown CL, Wollins DS, Brawley OW, Raghavan D. American Society of Clinical Oncology policy statement: disparities in cancer care. J Clin Oncol 27:2881-2885, 2009.


Graham AC, Davis SM, Andrulis ED. Interdependent nucleocytoplasmic trafficking and interactions of Dis3 with Rrp6, the core exosome, and importin-alpha3. Traffic 10:499-513, 2009.


Graham AC, Kiss DL, Andrulis ED. Core exosome-independent roles for Rrp6 in cell cycle progression. Mol Biol Cell 20:2242-2253, 2009. PMCID: PMC2669031


Gray-McGuire C, Bochud M, Goodloe R, Elston RC. Genetic association tests: A method for the joint analysis of family and case-control data. Hum Genomics 4:2-20, 2009.


Gregory TK, Wald D, Chen Y, Vermaat JM, Xiong Y, Tse W. Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics. J Hematol Oncol 2:23, 2009. PMCID: PMC2700131


Gromova P, Ralea S, Lefort A, Libert F, Rubin BP, Erneux C, Vanderwinden JM. Kit K641E oncogene upregulates Sprouty homolog 4 and Trophoblast glycoprotein in interstitial cells of Cajal in a murine model of gastrointestinal stromal tumors. J Cell Mol Med 13:1536-1548, 2009.


Grozav AG, Chikamori K, Kozuki T, Grabowski DR, Bukowski RMWillard BKinter M, Andersen AH, Ganapathi R, Ganapathi MK. Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity. Nucleic Acids Res 37:382-392, 2009. PMCID: PMC2632902


Guda K, Moinova H, He J, Jamison O, Ravi L, Natale L, Lutterbaugh J, Lawrence E, Lewis S, Willson JK, Lowe JB, Wiesner GL, Parmigiani G, Barnholtz-Sloan JDawson D, Velculescu VE, Kinzler KW, Papadopoulos N, Vogelstein B, Willis JGerken TAMarkowitz SD. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. Proc Natl Acad Sci U S A 106:12921-129215, 2009. PMCID: PMC2722285


Guda K, Natale L, Lutterbaugh J, Wiesner GL, Lewis S, Tanner SM, Tomsic J, Valle L, de la Chapelle A, Elston RCWillis JMarkowitz SD. Infrequent detection of germline allele-specific expression of TGFBR1 in lymphoblasts and tissues of colon cancer patients. Cancer Res 69:4959-4961, 2009. PMCID: PMC2739986


Guenther UP, Jankowsky E. Helicase multitasking in ribosome assembly. Mol Cell 36:537-538, 2009.


Gulani V, Willatt JM, Blaimer M, Hussain HK, Duerk JL, Griswold MA. Effect of contrast media on single-shot echo planar imaging: Implications for abdominal diffusion imaging. J Magn Reson Imaging 30:1203-1208, 2009.


Guo M, Spitale RC, Volpini R, Krucinska J, Cristalli G, Carey PR, Wedekind JE. Direct Raman measurement of an elevated base pK(a) in the active site of a small ribozyme in a precatalytic conformation. J Am Chem Soc 131:12908-12909, 2009. PMCID: PMC2776658

Häfeli UO, Riffle JS, Harris-Shekhawat L, Carmichael-Baranauskas A, Mark F, Dailey JP, Bardenstein D. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm 6:1417-1428, 2009.


Haka AS, Volynskaya Z, Gardecki JA, Nazemi J, Shenk R, Wang N, Dasari RR, Fitzmaurice M, Feld MS. Diagnosing breast cancer using Raman spectroscopy: prospective analysis. J Biomed Opt 14:054023, 2009.


Haley M, Konski A, Li T, Cheng JD, Maurer A, Haluszka O, Scott W, Meropol NJ, Cohen SJ, Freedman G. Influence of diabetes on the interpretation of PET scans in patients with esophageal cancer. Gastrointest Cancer Res 3:149-152, 2009. PMCID: 2739639


Hall MA, Daly BJ, Madigan EA. Use of anecdotal notes by clinical nursing faculty: A descriptive study. J Nurs Educ 3:1-4, 2009.


Hamaneh MB, Buck M. Refinement of the primary hydration shell model for molecular dynamics simulations of large proteins. J Comput Chem 30:2635-2644, 2009. PMCID: 2760659


Hamrahian A, Weil RJ, Kennedy L. Contemporary issues in pituitary disease: Case-based management update. Expert Rev Endocrinol Metab 4:317-320, 2009.


Han F, Yu H, Tian C, Li S, Jacobs MR, Benedict-Alderfer C, Zheng QY. Role for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae infection in mouse otitis media. Infect Immun 77:3100-3108, 2009. PMCID: PMC2708554


Hansel DE, Nakayama M, Luo J, Abukhdeir AM, Park BH, Bieberich CJ, Hicks JL, Eisenberger M, Nelson WG, Mostwin JL, De Marzo AM. Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate. Prostate 69:603-609, 2009.


Hanson RW. A perspective on the biology of phosphoenolpyruvate carboxykinase 55 years after its discovery. J Biol Chem 284:27021-27023, 2009.


Harb D, Bujold K, Febbraio M, Sirois MG, Ong H, Marleau S. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation. Cardiovasc Res 83:42-51, 2009.


Hardacre JM, Simo K, McGee MF, Stellato TA, Schulak JA. Pancreatic resection in octogenarians. J Surg Res 156:129-132, 2009.


Hardy GA, Sieg SF, Rodriguez B, Jiang W, Asaad R, Lederman MMHarding CV. Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression. Blood 113:5497-5505, 2009. PMCID: PMC2689050


Hari PN, Zhang MJ, Roy V, Pérez WS, Bashey A, To LB, Elfenbein G, Freytes CO, Gale RP, Gibson J, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Pavlovsky S, Reece DE, Schiller G, Vela-Ojeda J, Weisdorf D, Vesole D. Is the international staging system superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia 23:1528-1534, 2009. PMCID: PMC2726276


Harr MW, Rong Y, Bootman MD, Roderick HL, Distelhorst CW. Glucocorticoid-mediated inhibition of LCK modulates the pattern of TCR-induced calcium signals by downregulatig IP3 receptors. J Biol Chem 284:31860-31871, 2009. PMCID: PMC2797257


Hartupee J, Liu C, Novotny M, Sun D, Li X, Hamilton TA. IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6. J Immunol 182:1660-1666, 2009. PMCID: PMC2665037


He X, Marchionni L, Hansel DE, Yu W, Sood A, Yang J, Parmigiani G, Matsui W, Berman DM. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells 27:1487-1495, 2009.


Heaney JD, Michelson MV, Youngren KK, Lam MY, Nadeau JH. Deletion of eIF2beta suppresses testicular cancer incidence and causes recessive lethality in agouti-yellow mice. Hum Mol Genet 18:1395-1404, 2009. PMCID: PMC2664146


Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8:3274-3284, 2009.


Heinberg LJ, Kutchman EM, Lawhun SA, Berger NA, Seabrook RC, Cuttler L, Horwitz SM. Parent involvement is associated with early success in obesity treatment. Clin Pediatr OnlineFirst, published online June 1, 2009.


Heliövaara E, Raitila A, Launonen V, Paetau A, Arola J, Lehtonen H, Sane T, Weil RJ, Vierimaa O, Salmela P, Tuppurainen K, Mäkinen M, Aaltonen LA, Karhu A. The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas. Am J Pathol 175:2501-2507, 2009. PMCID: PMC2789606


Heng DY, Chi KN, Murray N, Jin T, Garcia JA, Bukowski RM, Rini BI, Kollmannsberger C. A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer. Cancer 115:776-783, 2009.


Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: Results from a large, multicenter study. J Clin Oncol 27:5794-5799, 2009.


Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A 3rd, von Hoff D, Schuchter LM. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27:127-145, 2009.


Herlihy EP, Rubin BP, Jian-Amadi A. Primary myoepithelioma of the orbit in an infant. J AAPOS 13:303-305, 2009.


Hill-Baskin AE, Markiewski MM, Buchner DA, Shao H, Desantis D, Hsiao G, Subramaniam S, Berger NA, Croniger C, Lambris JD, Nadeau JH. Diet-induced hepatocellular carcinoma in genetically-predisposed mice. Hum Mol Genet 18:2975-2988, 2009. PMCID: PMC2714725


Himanen JP, Goldgur Y, Miao H, Myshkin E, Guo H, Buck M, Nguyen M, Rajashankar KR, Wang B, Nikolov DB. Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex. EMBO Rep 10:722-728. PMCID: PMC2727437


Hobert JA, Eng C. PTEN hamartoma tumor syndrome: An overview. Genet Med 11:687-694, 2009.


Hodges KB, Abdul-Karim FW, Wang M, Lopez-Beltran A, Montironi R, Easley S, Zhang S, Wang N, Maclennan GT, Cheng L. Evidence for transformation of fibroadenoma of the breast to malignant phyllodes tumor. Appl Immunohistochem Mol Morphol 17:345-350, 2009.


Hong S, Klein EA, Das Gupta J, Hanke K, Weight CJ, Nguyen C, Gaughan C, Kim KA, Bannert N, Kirchhoff F, Munch J, Silverman RH. Fibrils of prostatic acid phosphatase fragments boost infections by XMRV, a human retrovirus associated with prostate cancer. J Virol 83:6995-7003, 2009. PMCID: PMC2704761


Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, Johnson DH. A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group. J Thorac Oncol 4:527-533, 2009.


Horn L, Dahlberg SE, Sandler AB, Dowlati A, Moore DF, Murren JR, Schiller JH. Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501. J Clin Oncol 27:6006-6011, 2009. PMCID: PMC2793043


Hoskin PJ, Lowry L, Horwich A, Jack A, Mead B, Hancock BW, Smith P, Qian W, Patrick P, Popova B, Pettitt A, Cunningham D, Pettengell R, Sweetenham J, Linch D, Johnson PW. Randomized comparison of the Stanford V Regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. J Clin Oncol 27:5390-5396, 2009.


Hossain M, Sathe T, Fazio V, Mazzone P, Weksler B, Janigro D, Rapp E, Cucullo L. Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier. Brain Res 1287:192-205, 2009.


Hota PK, Buck M. Thermodynamic characterization of two homologous protein complexes: associations of the semaphorin receptor plexin-B1 RhoGTPase binding domain with Rnd1 and active Rac1. Protein Sci 18:1060-1071, 2009. PMCID: 2771308


Hsi ED. The leukemias of mature lymphocytes. Hematol Oncol Clin North Am 23:843-871, 2009.


Hsi ED. T-cell lymphoma in the head and neck? Think about adult T-cell leukemia/lymphoma. Leuk Lymphoma 50:150-151, 2009.


Hsi ED. The role of biomarkers in the management of patients with lymphoma: promise versus reality. Clin Lymphoma Myeloma 9:121-123, 2009.


Hu Y, Lu X, Zhou G, Barnes EL, Luo G. Recql5 plays an important role in DNA replication and cell survival after camptothecin treatment. Mol Biol Cell 20:114-123, 2009. PMCID: PMC2613109


Hua QX, Xu B, Huang K, Hu SQ, Nakagawa S, Jia W, Wang S, Whittaker J, Katsoyannis PG, Weiss MA. Enhancing the activity of a protein by stereospecific unfolding: conformational life cycle of insulin and its evolutionary origins. J Biol Chem 284:14586-14596, 2009. PMCID: PMC2682906


Hudes GR, Berkenblit A, Feingold J, Atkins MB, Rini BI, Dutcher J. Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma. Semin Oncol 36 Suppl 3:S26-36, 2009.


Hulgan T, Donahue JP, Smeaton L, Pu M, Wang H, Lederman MM, Smith K, Valdez H, Pilcher C, Haas DW; AIDS Clinical Trials Group Study A5138 Team. Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors. Eur J Clin Pharmacol 65:1081-1088, 2009.


Hurwitz HI, Dowlati A, Saini S, Savage S, Suttle AB, Gibson DM, Hodge JP, Merkle EM, Pandite L. Phase I trial of pazopanib in patients with advanced cancer. Clin Cancer Res 15:4220-4227, 2009.


Hussain MH, Wood DP, Bajorin DF, Bochner BH, Dreicer R, Lamm DL, O'Donnell MA, Siefker-Radtke AO, Theodorescu D, Dinney CP. Bladder cancer: Narrowing the gap between evidence and practice. J Clin Oncol 27:5680-5684, 2009.

Iannotti CA, Hall GS, Procop GW, Tuohy MJ, Staugaitis SM, Weil RJ. Solitary Nocardia farcinica brain abscess in an immunocompetent adult mimicking metastatic brain tumor: rapid diagnosis by pyrosequencing and successful treatment. Surg Neurol 72:74-79, 2009.


Im E, Choi YJ, Kim CH, Fiocchi C, Pothoulakis C, Rhee SH. The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8. Am J Physiol Gastrointest Liver Physiol (September 3, 2009).doi:10.1152/ajpgi.00204.2009 PMCID: PMC2777460


Induru RR, Davis MP. Buprenorphine for neuropathic pain: Targeting hyperalgesia. Am J Hosp Palliat Care 26:470-473, 2009.


Ireland DD, Stohlman SA, Hinton DR, Kapil P, Silverman RH, Atkinson RA, Bergmann CC. RNase L mediated protection from virus induced demyelination. PoS Pathog 5:e1000602, 2009. PMCID: PMC2745574


Irwin BH, Gill IS, Haber GP, Campbell SC. Laparoscopic radical cystectomy: current status, outcomes, and patient selection. Curr Treat Options Oncol 10:243-255, 2009.


Ithychanda SS, Das M, Ma YQ, Ding K, Wang X, Gupta S, Wu C, Plow EF, Qin J. Migfilin: a molecular switch in regulation of integrin activation. J Biol Chem 284:4713-4722, 2009. PMCID: PMC2640964


Ithychanda SS, Hsu D, Li H, Yan L, Liu D, Das M, Plow EF, Qin J. Identification and characterization of multiple similar ligand binding repeats in filamin: Implication on filamin-mediated receptor clustering and cross-talking. J Biol Chem 284:35113-35121, 2009. PMCID: PMC2787372

Jacob AI, Romigh T, Waite KA, Eng C. Nuclear PTEN levels and G2 progression in melanoma cells. Melanoma Res 19:203-210, 2009. PMCID: PMC2750820


Jacob AI, Waite KA, Eng C. Cost-effective method for growing three-dimensional cell cultures in extracellular matrix extract. Biotech Histochem 84:25-28, 2009.


Jagdis A, Rubin BP, Tubbs RR, Pacheco M, Nielsen TO. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma. Am J Surg Pathol 33:1743-1751, 2009.


Jain AK, Hughes RS, Sandler AB, Dowlati A, Schwartzberg LS, Dobbs T, Schlabach L, Wu J, Muldowney NJ, Choy H. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC). J Thorac Oncol 4:722-727, 2009.


Jain TK, Foy SP, Erokwu B, Dimitrijevic S, Flask CALabhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials 30:6748-6756, 2009. PMCID: 2763936


Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood 113:6403-6410, 2009.


Jeon O, Bouhadir KH, Mansour JM, Alsberg E. Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties. Biomaterials 30:2724-2734, 2009.


Jiang J, Nguyen T, Rao JS. A simplified adaptive fence procedure. Stat Probability Lett 79:625-629, 2009.


Jiang W, Lederman MM, Hunt P, Sieg SF, Haley K, Rodriguez B, Landay A, Martin J, Sinclair E, Asher AI, Deeks SG, Douek DC, Brenchley JM. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 199:1177-1185, 2009.


Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 113:1315-1325, 2009. PMCID: PMC2637194


Jiang Y, Luo W, Howe PH. Dab2 stabilizes Axin and attenuates Wnt/beta-catenin signaling by preventing protein phosphatase 1 (PP1)-Axin interactions. Oncogene 28:2999-3007, 2009.


Jin S, Labhasetwar V. Nanotechnology in urology. Urol Clin North Am 36:179-188, 2009. PMCID: PMC2676239


Joe B, Saad Y, Lee NH, Frank BC, Achinike OH, Luu TV, Gopalakrishnan K, Toland EJ, Farms P, Yerga-Woolwine S, Manickavasagam E, Rapp JP, Garrett MR, Coe D, Apte SS, Rankinen T, Pérusse L, Ehret GB, Ganesh SK, Cooper RS, O'Connor A, Rice T, Weder AB, Chakravarti A, Rao DC, Bouchard C. Positional identification of variants of Adamts16 linked to inherited hypertension. Hum Mol Genet 18:2825-2838, 2009. PMCID: PMC2706685


Jones CV, Copelan EA. Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation. Future Oncol 5:559-568, 2009.


Johnson MD, Moots PL, Zhuang Z, Weil RJ. Molecular genetic analysis of a primitive neuroectodermal tumor arising after intracranial radiation and chemotherapy for leukemia. Ann Clin Lab Sci 39:295-302, 2009.


Jou P, Maclennan GT. Leydig cell tumor of the testis. J Urol 181:2299-2300, 2009.


Jun G, Guo H, Klein BE, Klein R, Wang JJ, Mitchell P, Miao H, Lee KE, Joshi T, Buck M, Chugha P, Bardenstein D, Klein AP, Bailey-Wilson JE, Gong X, Spector TD, Andrew T, Hammond CJ, Elston RCIyengar SK, Wang B. EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet 5:e1000584, 2009. PMCID: PMC2712078

Jacob AI, Romigh T, Waite KA, Eng C. Nuclear PTEN levels and G2 progression in melanoma cells. Melanoma Res 19:203-210, 2009. PMCID: PMC2750820


Jacob AI, Waite KA, Eng C. Cost-effective method for growing three-dimensional cell cultures in extracellular matrix extract. Biotech Histochem 84:25-28, 2009.


Jagdis A, Rubin BP, Tubbs RR, Pacheco M, Nielsen TO. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma. Am J Surg Pathol 33:1743-1751, 2009.


Jain AK, Hughes RS, Sandler AB, Dowlati A, Schwartzberg LS, Dobbs T, Schlabach L, Wu J, Muldowney NJ, Choy H. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC). J Thorac Oncol 4:722-727, 2009.


Jain TK, Foy SP, Erokwu B, Dimitrijevic S, Flask CALabhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials 30:6748-6756, 2009. PMCID: 2763936


Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood 113:6403-6410, 2009.


Jeon O, Bouhadir KH, Mansour JM, Alsberg E. Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties. Biomaterials 30:2724-2734, 2009.


Jiang J, Nguyen T, Rao JS. A simplified adaptive fence procedure. Stat Probability Lett 79:625-629, 2009.


Jiang W, Lederman MM, Hunt P, Sieg SF, Haley K, Rodriguez B, Landay A, Martin J, Sinclair E, Asher AI, Deeks SG, Douek DC, Brenchley JM. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 199:1177-1185, 2009.


Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 113:1315-1325, 2009. PMCID: PMC2637194


Jiang Y, Luo W, Howe PH. Dab2 stabilizes Axin and attenuates Wnt/beta-catenin signaling by preventing protein phosphatase 1 (PP1)-Axin interactions. Oncogene 28:2999-3007, 2009.


Jin S, Labhasetwar V. Nanotechnology in urology. Urol Clin North Am 36:179-188, 2009. PMCID: PMC2676239


Joe B, Saad Y, Lee NH, Frank BC, Achinike OH, Luu TV, Gopalakrishnan K, Toland EJ, Farms P, Yerga-Woolwine S, Manickavasagam E, Rapp JP, Garrett MR, Coe D, Apte SS, Rankinen T, Pérusse L, Ehret GB, Ganesh SK, Cooper RS, O'Connor A, Rice T, Weder AB, Chakravarti A, Rao DC, Bouchard C. Positional identification of variants of Adamts16 linked to inherited hypertension. Hum Mol Genet 18:2825-2838, 2009. PMCID: PMC2706685


Jones CV, Copelan EA. Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation. Future Oncol 5:559-568, 2009.


Johnson MD, Moots PL, Zhuang Z, Weil RJ. Molecular genetic analysis of a primitive neuroectodermal tumor arising after intracranial radiation and chemotherapy for leukemia. Ann Clin Lab Sci 39:295-302, 2009.


Jou P, Maclennan GT. Leydig cell tumor of the testis. J Urol 181:2299-2300, 2009.


Jun G, Guo H, Klein BE, Klein R, Wang JJ, Mitchell P, Miao H, Lee KE, Joshi T, Buck M, Chugha P, Bardenstein D, Klein AP, Bailey-Wilson JE, Gong X, Spector TD, Andrew T, Hammond CJ, Elston RCIyengar SK, Wang B. EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet 5:e1000584, 2009. PMCID: PMC2712078

Kahana E, Kahana B, Kelley-Moore J, Adams SA, Hammel R, Kulle D, Brown JA, King C. Toward advocacy in cancer care for older adults: survivors have cautious personal actions but bold advice for others. J Am Geriatr Soc 57 Suppl 2:S269-271, 2009.


Kalaycio M. Bendamustine: a new look at an old drug. Cancer 115:473-479, 2009.


Kalaycio M, Wendtner CM. Review: what causes neurotoxicity after exposure to purine analogs? Clin Adv Hematol Oncol 7:745-746, 2009.


Kalp M, Bethel CR, Bonomo RA, Carey PR. Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors. Biochemistry 48:9912-9920, 2009. PMCID: 2770726


Kalp M, Buynak JD, Carey PR. Role of E166 in the imine to enamine tautomerization of the clinical beta-lactamase inhibitor sulbactam. Biochemistry 48:10196-10198, 2009. PMCID: PMC2783953


Kalp M, Totir MA, Buynak JD, Carey PR. Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: raman crystallographic evidence. J Am Chem Soc 131:2338-2347, 2009. PMCID: PMC2661619


Kaneshiro D, Kobayashi T, Chao STSuh J, Prayson RA. Chromosome 1p and 19q deletions in glioblastoma multiforme. Appl Immunohistochem Mol Morphol 17:512-516, 2009.


Kang SJ, Larkin EK, Song Y, Barnholtz-Sloan J, Baechle D, Feng T, Zhu X. Assessing the impact of global versus local ancestry in association studies. BMC Proc 3 Suppl 7:S107, 2009. PMCID: PMC2795878


Kariv R, Plesec TP, Goldblum JR, Bronner M, Oldenburgh M, Rice TW, Falk GW. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol 7:653-658, 2009.


Kariv Y, Remzi FH, Strong SA, Hammel JP, Preen M, Fazio VW. Ileal pouch rectal anastomosis: a viable alternative to permanent ileostomy in Crohn's proctocolitis patients. J Am Coll Surg 208:390-399, 2009.


Kashyap SR, Ioachimescu AG, Gornik HL, Gopan T, Davidson MB, Makdissi A, Major J, Febbraio MSilverstein RL. Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring) 17:2142-2148, 2009.


Kattan MW. Comparative effectiveness: a table of expected benefits and harms. Med Decis Making 29:NP3-5, 2009.


Kattan MW. Prediction models for transitional cell carcinoma. J Urol 182:423-424, 2009.


Kattan MW. Editorial comment [Prostogram predicted brachytherapy outcomes are not universally accurate: An analysis based on the M. D. Anderson Cancer Center experience with 125Iodine brachytherapy]. J Urol 181:1663, 2009.


Kattan MW. Editorial comment: Significant change in predicted risk of biochemical recurrence after radical prostatectomy more common in black then in white men. Urology 74:664, 2009.


Kattan MW, Vickers AJ, Yu C, Bianco FJ, Cronin AM, Eastham JA, Klein EA, Reuther AM, Edson Pontes J, Scardino PT. Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer. Cancer 115:1005-1010, 2009.


Kaur B, Cork SM, Sandberg EM, Devi NS, Zhang Z, Klenotic PA, Febbraio M, Shim H, Mao H, Tucker-Burden C, Silverstein RL, Brat DJ, Olson JJ, Van Meir EG. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism. Cancer Res 69:1212-1220, 2009. PMCID: PMC2659670


Kaur P, Kiselar JG, Chance MR. Integrated algorithms for high-throughput examination of covalently labeled biomolecules by structural mass spectrometry. Anal Chem 81:8141-8149, 2009. PMCID: PMC2764328


Kawanami D, Mahabeleshwar GH, Lin Z, Atkins GB, Hamik A, Haldar SM, Maemura K, Lamanna JC, Jain MK. Kruppel-like factor 2 inhibits hypoxia-inducible-factor-1alpha expression and function in the endothelium. J Biol Chem 284:20522-20530, 2009.


Kawsar HI, Weinberg A, Hirsch SA, Venizelos A, Howell S, Jiang B, Jin G. Overexpression of human beta-defensin-3 in oral dysplasia: potential role in macrophage trafficking. Oral Oncol 45:696-702, 2009.


Kaye NM, Emmett KJ, Merrick WCJankowsky E. Intrinsic RNA binding by the eukaryotic initiation factor 4F depends on a minimal RNA length but not on the m7G cap. J Biol Chem 284:17742-17750, 2009.


Ke E, Patel BB, Liu T, Li XM, Haluszka O, Hoffman JP, Ehya H, Young NA, Watson JC, Weinberg DS, Nguyen MT, Cohen SJ, Meropol NJ, Litwin S, Tokar JL, Yeung AT. Proteomic analyses of pancreatic cyst fluids. Pancreas 38:e33-42, 2009. PMCID: PMC2681236


Ke T, Gomez CR, Mateus HE, Castano JA, Wang QK. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American family. J Hum Genet 54:660-664, 2009.


Kearney KE, Pretlow TGPretlow TP. Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention. Int J Cancer 125:249-252, 2009.


Kelley CG, Lipson AR, Daly BJ, Douglas SL. Advance directive use and psychosocial characteristics: an analysis of patients enrolled in a psychosocial cancer registry. Cancer Nurs 32:335-341, 2009.


Kessel D, Oleinick NL. Initiation of autophagy by photodynamic therapy. Methods Enzymol 453:1-16, 2009.


Khan MK, Hunter GK, Vogelbaum M, Suh JH, Chao ST. Evidence-based adjuvant therapy for gliomas: current concepts and newer developments. Indian J Cancer 46:96-107, 2009.


Khatri BO, Man S, Giovannoni G, Koo AP, Lee JC, Tucky B, Lynn F, Jurgensen S, Woodworth J, Goelz S, Duda PW, Panzara MA, Ransohoff RM, Fox RJ. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72:402-409, 2009. PMCID: PMC2677532


Kikano G. Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections. Postgrad Med 121:173-175, 2009.


Kim JJ, Rini BI. Recent advances in molecularly targeted therapy in advanced renal cell carcinoma. Therapy 6:309-320, 2009.


Kim K, Dean D, Mikos AG, Fisher JP. Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromolecules 10:1810–1817, 2009.


Kim S, Shen T, Min B. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes. J Immunol 183:3033-3039, 2009.


Kim S, von Recum HA. Endothelial progenitor populations in differentiating embryonic stem cells I: identification and differentiation kinetics. Tissue Eng Part A 15:3709-3718, 2009.


Kindwall-Keller T, Isola LM. The evolution of hematopoietic SCT in myelodysplastic syndrome. Bone Marrow Transplant 43:597-609, 2009.


Kinney CM, Chandrasekharan UM, Yang L, Shen J, Kinter M, McDermott MS, DiCorleto PE. Histone H3 as a novel substrate for MAP kinase phosphatase-1. Am J Physiol Cell Physiol 296:C242-249, 2009. PMCID: PMC2643854


Kirkwood JM, Jukic DM, Averbook BJ, Sender LS. Melanoma in pediatric, adolescent, and young adult patients. Semin Oncol 36:419-431, 2009. PMCID: PMC2797485


Kisby GE, Olivas A, Park T, Churchwell M, Doerge D, Samson LD, Gerson SL, Turker MS. DNA repair modulates the vulnerability of the developing brain to alkylating agents. DNA Repair 8:400-412, 2009. PMCID: PMC2692311


Kiser PD, Golczak M, Lodowski DT, Chance MR, Palczewski K. Crystal structure of native RPE65, the retinoid isomerase of the visual cycle. Proc Natl Acad Sci U S A 106:17325-17330, 2009. PMCID: 2765077


Klein EA. Selenium and vitamin E: interesting biology and dashed hope. J Natl Cancer Inst 101:283-285, 2009.


Klein EA. What's new in prostate cancer screening and prevention? Cleve Clin J Med 76:439-445, 2009.


Klein EACiezki J, Kupelian PA, Mahadevan A. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy? Urol Oncol 27:67-71, 2009.


Kluge A, Dabir S, Kern J, Nethery D, Halmos BMa PDowlati A. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer. Int J Cancer 125:1728-1734, 2009. PMCID: 2764252


Knight D, Peterson AC, Rini BI, Harlin H, Gajewski TF, Stadler WM. The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer. Prostate 69:142-148, 2009.


Ko JS, Bukowski RMFinke JH. Myeloid-derived suppressor cells: a novel therapeutic target. Curr Oncol Rep 11:87-93, 2009.


Ko JS, Zea AH, Rini BI, Ireland JL, Elson P, Cohen P, Golshayan A, Rayman PA, Wood L, Garcia JDreicer RBukowski RFinke JH. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res 15:2148-2157, 2009.


Koeck T, Willard B, Crabb JW, Kinter M, Stuehr DJ, Aulak KS. Glucose-mediated tyrosine nitration in adipocytes: targets and consequences. Free Radic Biol Med 46:884-892, 2009.


Kombu RS, Zhang G, Abbas R, Mieyal JJ, Anderson VE, Kelleher JK Phd, Sanabria JR, Brunengraber H. Dynamics of glutathione and ophthalmate traced with 2H-enriched body water in rats and humans. Am J Physiol Endocrinol Metab 297:E260-E269, 2009. PMCID: PMC2711657


Konski A, Li T, Sigurdson E, Cohen SJ, Small W Jr, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys 74:55-59, 2009.


Koroukian SM. Assessment and interpretation of comorbidity burden in older adults with cancer. J Am Geriatr Soc 57 Suppl 2:S275-278, 2009.


Koroukian SM, Dahman B, Copeland G, Bradley CJ. The utility of the state buy-in variable in the Medicare denominator file to identify dually eligible Medicare-Medicaid beneficiaries: A validation study. Health Serv Res 45:265-282, 2009.


Korver W, Zhao X, Singh S, Pardoux C, Zhao J, Guzman ML, Sen S, Yonkovich S, Liu S, Zhan X, Tomasevic N, Zhou C, Gros D, Jordan CT, Gotlib J, Hsi ED, Abo A. Monoclonal antibodies against IREM-1: potential for targeted therapy of AML. Leukemia 23:1587-1597, 2009.


Koschmieder S, Halmos B, Levantini E, Tenen DG. Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol 27:619-628, 2009. PMCID: PMC2645860


Krebs MD, Erb RM, Yellen BB, Samanta B, Bajaj A, Rotello VM, Alsberg E. Formation of ordered cellular structures in suspension via label-free negative magnetophoresis. Nano Lett 9:1812-1817, 2009. PMCID: PMC2681786


Krebs MD, Jeon O, Alsberg E. Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels. J Am Chem Soc 131:9204-9206, 2009.


Krebs MD, Sutter KA, Lin AS, Guldberg RE, Alsberg E. Injectable poly(lactic-co-glycolic) acid scaffolds with in situ pore formation for tissue engineering. Acta Biomater 5:2847-2859, 2009.


Krishnamurthi SS, Brell JM, Hoppel CL, Egorin MJ, Weaver KC, Li X, Ingalls ST, Zuhowski EG, Schluchter MD, Dowlati A, Cooney MMGibbons J, Overmoyer BA, Ivy SP, Remick SC. Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine. Cancer Chemother Pharmacol 63:441-450, 2009.


Krishnaswamy S, Kanteti R, Duke-Cohan JS, Loganathan S, Liu W, Ma PC, Sattler M, Singleton PA, Ramnath N, Innocenti F, Nicolae DL, Ouyang Z, Liang J, Minna J, Kozloff MF, Ferguson MK, Natarajan V, Wang YC, Garcia JG, Vokes EE, Salgia R. Ethnic differences and functional analysis of MET mutations in lung cancer. Clin Cancer Res 15:5714-5723, 2009.


Krupka TM, Dremann D, Exner AA. Time and dose dependence of Pluronic bioactivity in hyperthermia-induced tumor cell death. Exp Biol Med (Maywood) 234:95-104, 2009.


Kubicek GJ, Wearner-Wasik M, Machtay M, Mallon G, Myers T, Ramirez M, Andrews D, Curran WJ Jr, Dicker AP. Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies. Int J Radiat Oncol Biol Phys 74:433-439, 2009.


Kudahetti S, Fisher G, Ambroisine L, Foster C, Reuter V, Eastham J, Møller H, Kattan MW, Cooper CS, Scardino P, Cuzick J, Berney DM. p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer. BJU Int 104:20-24, 2009.


Kumar A, Hoffman TA, Dericco J, Naqvi A, Jain MK, Irani K. Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc. FASEB J 23:4344-4352, 2009.


Kumon RE, Pollack MJ, Faulx AL, Olowe K, Farooq FT, Chen VK, Zhou Y, Wong RC, Isenberg GA, Sivak MV, Chak ADeng CX. Characterization of pancreatic cancer and intra-abdominal lymph node malignancy using spectrum analysis of endoscopic ultrasound imaging. Conf Proc IEEE Eng Med Biol Soc 1:1949-1952, 2009.


Kunos C, Chen W, Debernardo R, Waggoner S, Brindle J, Zhang Y, Williams J, Einstein D. Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies. Technol Cancer Res Treat 8:393-400, 2009.


Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node sesection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol 114:537-546, 2009.


Kunos C, Tian C, Waggoner SRose PG, Lanciano R. Retrospective analysis of concomitant cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: A Gynecologic Oncology Group Study. Int J Gynecol Cancer 19:1258-1263, 2009.


Kunos CA, Chiu SM, Pink J, Kinsella TJ. Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein. Radiat Res 172:666-676, 2009. PMCID: PMC2818576


Kwon EJ, Kristjansson AK, Meyerson HJ, Fedele GM, Tung RC, Sellheyer K, Tuthill RJ, Honda KS, Gilliam AC, McNiff JM. A case of recurrent pseudolymphomatous folliculitis: a mimic of cutaneous lymphoma. J Am Acad Dermatol 60:994-1000, 2009.

Labhasetwar V, Zborowski M, Abramson AR, Basilion JP. Nanoparticles for imaging, diagnosis, and therapeutics. Mol Pharm 6:1261-1262, 2009.


Lacy S, Lopez-Beltran A, MacLennan GT, Foster SR, Montironi R, Cheng L. Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. Anal Quant Cytol Histol 31:5-16, 2009.


Laframboise T. Single nucleotide polymorphism arrays: a decade of biological, computational and technological advances. Nucleic Acids Res 37:4181-4193, 2009. PMCID: PMC2715261


Laframboise T, Winckler W, Thomas RK. A flexible rank-based framework for detecting copy number aberrations from array data. Bioinformatics 25:722-728, 2009.


LaManna JC, Salem N, Puchowicz M, Erokwu B, Koppaka S, Flask CLee Z. Ketones suppress brain glucose consumption. Adv Exp Med Biol 645:301-306, 2009.


Lancioni C, Labeaud AD, Esper F, Abughali N, Auletta J. Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia. Pediatr Blood Cancer 53:1318-1320, 2009.


Landers SH, Gunn PW, Stange KC. An emerging model of primary care for older adults: the house call-home care practice. Care Manag J 10:110-114, 2009.


Lane BR, Poggio ED, Herts BR, Novick AC, Campbell SC. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol 182:435-444, 2009.


Lane BR, Tiong HY, Campbell SC, Fergany AF, Weight CJ, Larson BT, Novick AC, Flechner SM. Management of the adrenal gland during partial nephrectomy. J Urol 181:2430-2436, 2009.


Lanham HJ, McDaniel RR Jr, Crabtree BF, Miller WL, Stange KC, Tallia AF, Nutting P. How improving practice relationships among clinicians and nonclinicians can improve quality in primary care. Jt Comm J Qual Patient Saf 35:457-466, 2009.


Lassen KG, Lobritz MA, Bailey JR, Johnston S, Nguyen S, Lee B, Chou T, Siliciano RF, Markowitz M, Arts EJ. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog 5:e1000377, 2009. PMCID: PMC2661022


Laughlin MJ. ISCT presidential editorial. Cytotherapy 11:2, 2009.


Lawson PJ, Flocke SA. Teachable moments for health behavior change: a concept analysis. Patient Educ Couns 76:25-30, 2009. PMCID: PMC2733160


Lawson PJ, Flocke SA, Casucci B. Development of an instrument to document the 5A's for smoking cessation. Am J Prev Med 37:248-254, 2009. PMCID: PMC2735336


Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M. Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. Biol Blood Marrow Transplant 15:589-596, 2009. PMCID: PMC2688780


Lederman MM, Este J. Targeting a host element as a strategy to block HIV replication: is it nice to fool with Mother Nature? Curr Opin HIV AIDS 4:79-81, 2009.


Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA. The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 174:891-897, 2009. PMCID: PMC2665749


Lee HG, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, Petersen RB, Bajic V, Smith MA. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem Int 54:84-88, 2009.


Lee HG, Zhu X, Casadesus G, Pallàs M, Camins A, O'Neill MJ, Nakanishi S, Perry G, Smith MA. The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival. Brain Res 1249:244-250, 2009. PMCID: 2698437


Lee HP, Casadesus G, Zhu X, Lee HG, Perry G, Smith MA, Gustaw-Rothenberg K, Lerner A. All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Rev Neurother 9:1615-1621, 2009.


Lee HP, Zhu X, Zhu X, Skidmore SC, Perry G, Sayre LM, Smith MA, Lee HG. The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells. J Neurochem 108:1434-1441, 2009. PMCID: PMC2677392


Lee IH, Piert M, Gomez-Hassan D, Junck L, Rogers L, Hayman J, Ten Haken RK, Lawrence TS, Cao Y, Tsien C. Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 73: 479-485, 2009. PMCID: PMC2652133


Lee MC, Aron M, Hsi ED, Herts BR, Pohlman B, Gill IS. Age-related Epstein-Barr virus-associated lymphoproliferative disorder presenting as renal mass. Urology 74:505-508, 2009.


Leidner RSFu P, Clifford B, Hamdan A, Jin C, Eisenberg R, Bogon TJ, Skokan M, Franklin WA, Cappuzzo F, Hirsch FR, Varella-Garcia M, Halmos B. Genetic abnormalities of the EGFR pathway in Africa American patients with non-small cell lung cancer. J Clin Oncol 27:5620-5626, 2009.


Lemieux H, Hoppel CL. Mitochondria in the human heart. J Bioenerg Biomembr 41:99-106, 2009.


Leonard JP, Williams ME, Goy A, Grant S, Pfreundschuh M, Rosen ST, Sweetenham JW. Mantle cell lymphoma: biological insights and treatment advances. Clin Lymphoma Myeloma 9:267-277, 2009.


Leussis MP, Frayne ML, Saito M, Berry EM, Aldinger KA, Rockwell GN, Hammer RP Jr, Baskin-Hill AE, Singer JB, Nadeau JH, Sklar P, Petryshen TL. Genomic survey of prepulse inhibition in mouse chromosome substitution strains. Genes Brain Behav 8:806-816, 2009.


Levy MJ, Chak A. EUS 2008 Working Group document: evaluation of EUS-guided vascular therapy. EUS 2008 Working Group. Gastrointest Endosc 69(2 Suppl):S37-42, 2009. PMCID: PMC2648852


Li C, Yu S, Nakamura F, Yin S, Xu J, Petrolla AA, Singh NTartakoff A, Abbott DW, Xin W, Sy MS. Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest 119:2725-2736, 2009. PMCID: PMC2735930


Li J, Li LK, Ma JF, Wei LH, Niyazi M, Li CQ, Xu AD, Wang JB, Liang H, Belinson J, Qiao YL. Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine 27:1210-1215, 2009.


Li L, Xu YWald DN, Tse W. Determination of 6-benzylthioinosine in mouse and human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:3871-3877, 2009.


Li LS, Morales JC, Veigl MSedwick D, Greer S, Meyers M, Wagner M, Fishel R, Boothman DA. DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets. Br J Pharmacol 158:679-692, 2009. PMCID: 2765589


Li M, Chen WD, Papadopoulos N, Goodman SN, Bjerregaard NC, Laurberg S, Levin B, Juhl H, Arber N, Moinova H, Durkee K, Schmidt K, He Y, Diehl F, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW, Markowitz SD, Vogelstein B. Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 27:858-863, 2009.


Li M, Ransohoff RM. The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis. Semin Cancer Biol 19:111-115, 2009.


Li X, Qi X, Zhou L, Fu W, Abdul-Karim FW, Maclennan GGorodeski GI. P2X(7) receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin. Purinergic Signal 5:351-368, 2009. PMCID: PMC2717318


Li Z, Bao S, Wu Q, Wang H, Eyler CE, Sathornsumetee S, Shi Q, Cao Y, Lathia JD, McLendon RE, Hjelmeland AB, Rich JN. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15:501-13, 2009.


Lin MC, Lomo L, Baak JP, Eng C, Ince TA, Crum CP, Mutter GL. Squamous morules are functionally inert elements of premalignant endometrial neoplasia. Mod Pathol 22:167-174, 2009. PMCID: PMC2633489


Lindner DRaghavan D. Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines. Br J Cancer 100:1287-1291, 2009.


Liotta M, Rose PG, Escobar PF. Pulmonary hypertension in two patients treated with bevacizumab for recurrent ovarian cancer. Gynecol Oncol 115:308-309, 2009.


Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 301:39-51, 2009.


Liu H, Yang Q, Radhakrishnan K, Whitfield DE, Everhart CL, Parsons-Wingerter P, Fisher SA. Role of VEGF and tissue hypoxia in patterning of neural and vascular cells recruited to the embryonic heart. Dev Dyn 38:2760-2769, 2009.


Lobo GP, Waite KA, Planchon SM, Romigh T, Nassif NT, Eng C. Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function. Hum Mol Genet 18:2851-2862, 2009. PMCID: PMC2706686


Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326:585-589, 2009.


Longpré JM, McCulloch DR, Koo BH, Alexander JP, Apte SS, Leduc R. Characterization of proADAMTS5 processing by proprotein convertases. Int J Biochem Cell Biol 41:1116-1126, 2009.


Lott S, Wang M, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R, Sung MT, Tan PH, Cheng L. FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations. Mod Pathol 22:627-632, 2009.


Lu T, Jackson MW, Singhi AD, Kandel ES, Yang M, Zhang Y, Gudkov AV, Stark GR. Validation-based insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFkappaB. Proc Natl Acad Sci U S A 106:16339-16344, 2009. PMCID: PMC2736141

Macarenco RS, Erickson-Johnson M, Wang X, Folpe AA, Rubin BP, Nascimento AG, Oliveira AM. Retroperitoneal lipomatous tumors without cytologic atypia: Are they lipomas?: A Clinicopathologic and molecular study of 19 cases. Am J Surg Pathol 33:1470-1476, 2009.


Machtay M, Natwa M, Andrel J, Hyslop T, Anne PR, Lavarino J, Intenzo CM, Keane W. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31:195-201, 2009.


Maciejewski JP, Tiu RV, O'Keefe C. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies. Br J Haematol 146:479-488, 2009.


Maclennan GT, Cheng L. Solitary fibrous tumor of the kidney. J Urol 181:2731-2732, 2009.


Mahalaha SA, Cheruvu VK, Smyth KA. Oral cancer screening: Practices, knowledge, and opinions of dentists working in Ohio nursing homes. Spec Care Dentist 29:237-243, 2009.


Mahan CS, Thomas JJ, Boom WH, Rojas RE. CD4(+) CD25(high) Foxp3(3+) regulatory T cells downregulate human Vdelta2(+) T-lymphocyte function triggered by anti-CD3 or phosphoantigen. Immunology 127:398-407, 2009. PMCID: PMC2712108


Mahindra A, Bolwell BSobecks R, Rybicki L, Pohlman BDean R, Andresen S, Sweetenham JKalaycio MCopelan E. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol 146:310-316, 2009.


Mahindra A, Sobecks R, Rybicki L, Pohlman BDean R, Andresen S, Kalaycio MSweetenham JBolwell BCopelan E. Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation. Bone Marrow Transplant 146:310-316, 2009.


Mahon RN, Rojas RE, Fulton SA, Franko J, Harding CVBoom WH. Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T cell activation by interfering with proximal T cell receptor signaling. Infect Immun 77:4574-4583, 2009. PMCID: PMC2747961


Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. Br J Haematol 147:129-139, 2009. PMCID: PMC2748179


Majhail NS, DeFor TE, Lazarus HM, Burns LJ. Iron-overload after autologous hematopoietic cell transplantation. Leuk Res 33:578-579, 2009.


Maki RG, D'Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, Livingston MB, Cooney MM, Hensley ML, Mita MM, Takimoto CH, Kraft AS, Elias AD, Brockstein B, Blachère NE, Edgar MA, Schwartz LH, Qin LX, Antonescu CR, Schwartz GK. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol 27:3133-3140, 2009. PMCID: PMC2716936


Makishima H, Cazzolli H, Szpurka H, Dunbar A, Tiu R, Huh J, Muramatsu H, O'Keefe C, Hsi E, Paquette RL, Kojima S, List AF, Sekeres MA, McDevitt MA,Maciejewski JP. Mutations of E3 ubiquitin ligase Cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. J Clin Oncol 27:6109-6116, 2009.


Mamolen M, Andrulis ED. Characterization of the Drosophilamelanogaster Dis3 ribonuclease. Biochem Biophys Res Commun 390:529-534, 2009. PMCID: PMC2787996


Mani M, Carrasco DE, Zhang Y, Takada K, Gatt ME, Dutta-Simmons J, Ikeda H, Diaz-Griffero F, Pena-Cruz V, Bertagnolli M, Myeroff LLMarkowitz SD, Anderson KC, Carrasco DR. BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells. Cancer Res 69:7577-7586, 2009.


Manne SL, Coups EJ, Markowitz A, Meropol NJ, Haller D, Jacobsen PB, Jandorf L, Peterson SK, Lesko S, Pilipshen S, Winkel G. A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings. Ann Behav Med 37:207-217, 2009. PMCID: PMC2707254


Marcantonio NA, Boehm CA, Rozic RJ, Au A, Wells A, Muschler GF, Griffith LG. The influence of tethered epidermal growth factor on connective tissue progenitor colony formation. Biomaterials 30:4629-4638, 2009.


Marchi N, Betto G, Fazio V, Fan Q, Ghosh C, Machado A, Janigro D. Blood-brain barrier damage and brain penetration of antiepileptic drugs: role of serum proteins and brain edema. Epilepsia 50:664-677, 2009.


Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, Betto G, Batra A, Carlton E, Najm I, Granata T, Janigro D. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 33:171-181, 2009.


Marko NF, Gonugunta VA, Hamrahian AH, Usmani A, Mayberg MR, Weil RJ. Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation. J Neurosurg 111:540-544, 2009.


Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361:2449-2460, 2009. PMCID: PMC2843693


Markowitz SD, Itzkowitz SH, Berger BM. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med 150:816-817, 2009.


Marks DI, Paietta EM, Moorman AV, Richards SM, Buck G, Dewald G, Ferrando A, Fielding AK, Goldstone AH, Ketterling RP, Litzow MR, Luger SM, McMillan AK, Mansour M, Rowe JM, Tallman MS, Lazarus HM. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics and outcome from the large randomised prospective trial (UKALL XII/ECOG 2993). Blood 114:5136-5145, 2009. PMCID: PMC2792210


Martires KJ, Fu P, Polster AM, Cooper KDBaron ED. Factors that affect skin aging: a cohort-based survey on twins. Arch Dermatol 145:1375-1379, 2009.


Master AM, Rodriguez ME, Kenney MEOleinick NLGupta AS. Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in vitro PDT studies. J Pharm Sci 99:2386-2398, 2009.


Matsui MS, Hsia A, Miller JD, Hanneman K, Scull H, Cooper KDBaron E. Non-sunscreen photoprotection: antioxidants add value to a sunscreen. J Investig Dermatol Symp Proc 14:56-59, 2009.


Mazzoccoli JP, Feke DL, Baskaran H, Pintauro PN. Mechanical and cell viability properties of crosslinked low- and high-molecular weight poly(ethylene glycol) diacrylate blends. J Biomed Mater Res A 93A:558-566, 2009.


Mazzone PJ, Marchi N, Fazio V, Taylor JM, Masaryk T, Bury L, Mekhail T, Janigro D. Small vessel ischemic disease of the brain and brain metastases in lung cancer patients. PLoS One 4:e7242, 2009. PMCID: PMC2747277


McLain RF, Boehm CA, Rufo-Smith C, Muschler GF. Transpedicular aspiration of osteoprogenitor cells from the vertebral body: progenitor cell concentrations affected by serial aspiration. Spine J 9:995-1002, 2009.


McClendon MJ, Hernandez S, Smyth KA, Lerner AJ. Memantine and acetylcholinesterase inhibitor treatment in cases of CDR 0.5 or questionable impairment. J Alzheimers Dis 16:577-583, 2009.


McCulloch DR, Le Goff CL, Bhatt S, Dixon LJ, Sandy JD, Apte SS. Adamts5, the gene encoding a proteoglycan-degrading metalloprotease, is expressed by specific cell lineages during mouse embryonic development and in adult tissues. Gene Expr Patterns 9:314-323, 2009. PMCID: PMC2725439


McCulloch DR, Nelson CM, Dixon LJ, Silver DL, Wylie JD, Lindner V, Sasaki T, Cooley MA, Argraves WS, Apte SS. ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell 17:687-698, 2009. PMCID: PMC2780442


McFarland BC, Stewart J, Hamza A, Nordal R, Davidson D, Henkin J, Gladson CL. Plasminogen kringle 5 induces apoptosis of brain microvessel endothelial cells: Sensitization by radiation and requirement for GRP78 and LRP1. Cancer Res 69:5537-5545, 2009.


McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, Rajaraman P, Razavi P, Patoka J, Wiencke JK, Bondy ML, Wrensch M. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev 18:1118-1126, 2009. PMCID: PMC2667563


Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419-427, 2009.


Meropol NJ. The significance of circulating tumor cells as prognostic markers for colon cancer. Clin Adv Hematol Oncol 7:247-248, 2009.


Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE. American Society of Clinical Oncology Guidance Statement: The cost of cancer care. J Clin Oncol 27:3868-3874, 2009.


Messerschmitt PJ, Garcia RM, Abdul-Karim FW, Greenfield EM, Getty PJ. Osteosarcoma. J Am Acad Orthop Surg 17:515-527, 2009.


Miao H, Li DQ, Mukherjee A, Guo H, Petty A, Cutter J, Basilion JP, Sedor J, Wu J, Danielpour DSloan AE, Cohen ML, Wang B. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16:9-20, 2009.


Miao H, Wang B. Eph/ephrin signaling in epithelial development and homeostasis. Int J Biochem Cell Biol 41:762-770, 2009.


Miles RR, Mankey CC, Seiler CE 3rd, Smith LB, Teruya-Feldstein J, Hsi ED, Elenitoba-Johnson KS, Lim MS. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas. Hum Pathol 40:1731-1737, 2009.


Miller DS, Blessing JA, Krasner CN, Mannel RS, Hanjani P, Pearl ML, Waggoner SE, Boardman CH. Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group. J Clin Oncol 27:2686-2691, 2009.


Miller JP, Semaan M, Einstein D, Megerian CA, Maciunas RJ. Staged gamma knife radiosurgery after tailored surgical resection: a novel treatment paradigm for glomus jugulare tumors. Stereotact Funct Neurosurg 87:31-36, 2009.


Miller JP, Semaan MT, Maciunas RJEinstein DB, Megerian CA. Radiosurgery for glomus jugulare tumors. Otolaryngol Clin North Am 42:689-706, 2009.


Millward CA, Burrage LC, Shao H, Sinasac DS, Kawasoe JH, Hill-Baskin AE, Ernest SR, Gornicka A, Hsieh CW, Pisano S, Nadeau JH, Croniger CM. Genetic factors for resistance to diet-induced obesity and associated metabolic traits on mouse chromosome 17. Mamm Genome 20:71-82, 2009.


Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, Block BL, Brumme ZL, Brumme CJ, Baker B, Rothchild AC, Li B, Trocha A, Cutrell E, Frahm N, Brander C, Toth I, Arts EJ, Allen TM, Walker BD. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphotye recognition. J Virol 83:2743-2755, 2009. PMCID: PMC2648254


Miwa HE, Gerken TA, Huynh TD, Duesler LR, Cotter M, Hering TM. Conserved sequence in the aggrecan interglobular domain modulates cleavage by ADAMTS-4 and ADAMTS-5. Biochim Biophys Acta 1790:161-172, 2009. PMCID: PMC2656578


Mohan SR, Clemente MJ, Afable M, Cazzolli HN, Bejanyan N, Wlodarski MW, Lichtin AE, Maciejewski JP. Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia. Haematologica 94:1407-1414, 2009. PMCID: PMC2754957


Mohan SR, Maciejewski JP. Diagnosis and therapy of neutropenia in large granular lymphocyte leukemia. Curr Opin Hematol 16:27-34, 2009.


Moise AR, Lobo GP, Erokwu B, Wilson DL, Peck D, Alvarez S, Domínguez M, Alvarez R, Flask CA, de Lera AR, von Lintig J, Palczewski K. Increased adiposity in the retinol saturase-knockout mouse. FASEB J 24:1261-1270, 2009.


Monslow J, Sato N, Mack JA, Maytin EV. Wounding-induced synthesis of hyaluronic acid in organotypic epidermal cultures requires the release of heparin-binding EGF and activation of the EGFR. J Invest Dermatol 129:2046-2058, 2009.


Montañez-Wiscovich ME, Seachrist DD, Landis MD, Visvader J, Andersen B, Keri RA. LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression. Oncogene 28:3608-3618, 2009. PMCID: 2762490


Mooney CJ, Nagaiah G, Fu P, Wasman JK, Cooney MMSavvides PSBokar JADowlati A, Wang D, Agarwala SS, Flick SM, Hartman PH, Ortiz JD,Lavertu PN, Remick SC. A Phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid 19:233-240, 2009.


Moore HC. Do GnRH analogs protect against ovarian toxicity of chemotherapy? Breast Cancer Res Treat 117:569-570, 2009.


Moore RM, Redline RW, Kumar D, Mercer BM, Mansour JM, Yohannes E, Novak JB, Chance MR, Moore JJ. Differential expression of fibulin family proteins in the para-cervical weak zone and other areas of human fetal membranes. Placenta 30:335-341, 2009. PMCID: PMC2693720


Moore SM. Commentary on "realist evaluation as a framework for the assessment of teaching about the improvement of care". J Nurs Educ 48:667-668, 2009.


Moreira DM, Jayachandran J, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Stephenson AJ, Freedland SJ. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database. BJU Int 104:1452-1456, 2009.


Morris NJ, Elston R, Stein CM. Calculating asymptotic significance levels of the constrained likelihood ratio test with application to multivariate genetic linkage analysis. Stat Appl Genet Mol Biol 8:39, 2009.


Morrison BH, Haney R, Lamarre E, Drazba J, Prestwich GD, Lindner DJ. Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma. Oncogene 28:2383-2392, 2009.


Mosavel MSimon C, Oakar C, Meyer S. Cervical cancer attitudes and beliefs-a Cape Town community responds on World Cancer Day. J Cancer Educ 24:114-119, 2009.


Mosavel M, Thomas T. Daughter-initiated health advice to mothers: perceptions of African-American and Latina daughters. Health Educ Res 24:799-810, 2009.


Mosley JD, Keri RA. Intrinsic bias in breast cancer gene expression data sets. BMC Cancer 9:214, 2009. PMCID: PMC2711113


Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili R, Bjarnason GA, Garcia-Del-Muro X, Sosman JA, Solska E, Wilding G, Thompson JA, Kim ST, Chen I, Huang X, Figlin RA. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 27:3584-3590, 2009.


Moussa AS, Li J, Soriano M, Klein EA, Dong F, Jones JS. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer. BJU Int 103:43-48, 2009.


Movsas B, Moughan J, Sarna L, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Wasserman T, Bruner DW. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An Analysis of RTOG 9801. J Clin Oncol 27:5816-5822, 2009. PMCID: PMC2793002


Mukhopadhyay R, Jia J, Arif A, Ray PS, Fox PL. The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem Sci 34:324-331, 2009.


Murthy SC, Rozas MS, Adelstein DJ, Mason DP, Calhoun R, Rybicki LA, Feng J, Blackstone EH, Rice TW. Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer. J Thorac Oncol 4:395-403, 2009.


Mwanda WO, Orem J, Fu P, Banura C, Kakembo J, Onyango CA, Ness A, Reynolds S, Johnson JL, Subbiah V, Bako J, Wabinga H, Abdallah FK,Meyerson HJ, Whalen CC, Lederman MM, Black J, Ayers LW, Katongole-Mbidde E, Remick SC. Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa. J Clin Oncol 27:3480-3488, 2009. PMCID: PMC2717754

Nadeau JH. Transgenerational genetic effects on phenotypic variation and disease risk. Hum Mol Genet 18:R202-210, 2009. PMCID: PMC2758712


Namkung J, Elston RC, Yang JM, Park T. Identification of gene-gene interactions in the presence of missing data using the multifactor dimensionality reduction method. Genet Epidemiol 33:646-656, 2009. PMCID: 2766017


Neumann HP, Eng C. The approach to the patient with paraganglioma. J Clin Endocrinol Metab 94:2677-2683, 2009. PMCID: PMC2730863


Neumann HP, Erlic Z, Boedeker CC, Rybicki LA, Robledo M, Hermsen M, Schiavi F, Falcioni M, Kwok P, …et al, Eng C. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res 69:3650-3656, 2009.


Neznanov N, Gorbachev AV, Neznanova L, Komarov AP, Gurova KV, Gasparian AV, Banerjee AK, Almasan AFairchild RL, Gudkov AV. Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications. Cell Cycle 3960-3970, 2009.


Nguyen CT, Kattan MW. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling. Cancer 115:3039-3045, 2009.


Nguyen CT, Reuther AM, Stephenson AJKlein EA, Jones JS. The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival. J Urol 181:75-80, 2009.


Nguyen CT, Zelefsky MJ, Kattan MW. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer. Cancer 115:3121-3127, 2009.


Nibbe RK, Chance MR. Approaches to biomarkers in human colorectal cancer: looking back, to go forward. Biomark Med 3:385-396, 2009. PMCID: PMC2749258


Nibbe RK, Markowitz SMyeroff L, Ewing R, Chance M. Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. Mol Cell Proteomics 8:827-845, 2009. PMCID: PMC2667362


Nielsen R, Hubisz MJ, Hellmann I, Torgerson D, Andrés AM, Albrechtsen A, Gutenkunst R, Adams MD, Cargill M, Boyko A, Indap A, Bustamante CD, Clark AG. Darwinian and demographic forces affecting human protein coding genes. Genome Res 19:838-849, 2009. PMCID: PMC2675972


Nishijo K, Chen QR, Zhang L, McCleish AT, Rodriguez A, Cho MJ, Prajapati SI, Gelfond JA, Chisholm GB, Michalek JE, Aronow BJ, Barr FG, Randall RL, Ladanyi M, Qualman SJ, Rubin BP, LeGallo RD, Wang C, Khan J, Keller C. Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. Cancer Res 69:2902-2911, 2009.


Nishijo K, Hosoyama T, Bjornson CR, Schaffer BS, Prajapati SI, Bahadur AN, Hansen MS, Blandford MC, McCleish AT, Rubin BP, Epstein JA, Rando TA, Capecchi MR, Keller C. Biomarker system for studying muscle, stem cells, and cancer in vivo. FASEB J 23:2681-2690, 2009. PMCID: PMC2717773


Nock NL, Bock C, Neslund-Dudas C, Beebe-Dimmer J, Rundle A, Tang D, Jankowski M, Rybicki BA. Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity. Cancer Causes Control 20:1915–1926, 2009. PMCID: PMC2777237


Nock NL, Wang X, Thompson CL, Song Y, Baechle D, Raska P, Stein CM, Gray-McGuire C. Defining genetic determinants of the Metabolic Syndrome in the Framingham Heart Study using association and structural equation modeling methods. BMC Proc 15;3 Suppl 7:S50, 2009. PMCID: PMC2795950


Nolting J, Daniel C, Reuter S, Stuelten C, Li P, Sucov H, Kim BG, Letterio JJ, Kretschmer K, Kim HJ, von Boehmer H. Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J Exp Med 206:2131-2139, 2009. PMCID: 2757891


Nutting PA, Miller WL, Crabtree BF, Jaen CR, Stewart EE, Stange KC. Initial lessons from the first national demonstration project on practice transformation to a patient-centered medical home. Ann Fam Med 7:254-260, 2009. PMCID: PMC2682981

Obrenovich ME, Morales LA, Cobb CJ, Shenk JC, Méndez GM, Fischbach K, Smith MA, Qasimov EK, Perry G, Aliev G. Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation. J Cell Mol Med 13:853-865, 2009.


Olovnikov IA, Kravchenko JE, Chumakov PM. Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense. Semin Cancer Biol 19:32-41, 2009. PMCID: PMC2646792


Olson JA Jr, Budd GT, Carey LA, Harris LA, Esserman LJ, Fleming GF, Marcom PK, Leight GS Jr, Giuntoli T, Commean P, Bae K, Luo J, Ellis MJ. Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial. J Am Coll Surg 208:906-914, 2009.


Omay SB, Vogelbaum MA. Current concepts and newer developments in the treatment of malignant gliomas. Indian J Cancer 46:88-95, 2009.


O'Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT 4th; Family Healthware Impact Trial group: Yoon PW, Valdez R, La Cruz MI, Khoury MJ, Jorgensen C, Scheuner MT, O'Neill SM, Rubinstein WS, Rothrock N, Beaumont JL, Khan S, Ali D, Starzyk EJ, Wang C, Ruffin MT 4th, Nease D, Zyzanski SJWiesner GLWerner J, Gramling R, Pace WD, Galliher JM, Brandt E. Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med 36:506-514, 2009.


Oruganti P, Gratzl M. Temporal ratiometry to assess dynamic concentration distributions of fluorescent molecules in single live cells during continuous diffusional dosing. Anal Bioanal Chem 395:449-456, 2009.


O'Toole EStep MM, Engelhardt K, Lewis S, Rose JH. The role of primary care physicians in advanced cancer care: perspectives of older patients and their oncologists. J Am Geriatr Soc 57 Suppl 2:S265-268, 2009.


Owusu C. Clinical management update: evaluation and management of older patients with breast cancer. J Am Geriatr Soc 57 Suppl 2:S250-252, 2009.


Owusu C, Studenski SA. Shared care in geriatric oncology: primary care providers' and medical/oncologist's perspectives. Am Geriatr Soc 57 Suppl 2:S239-242, 2009.

Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R, Misek DE, Cooke KR, Kitko CL, Weyand A, Bickley D, Jones D, Whitfield J, Reddy P, Levine JE, Hanash SM, Ferrara JL. A biomarker panel for acute graft-versus-host disease. Blood 113:273-278, 2009. PMCID: PMC2615645


Palmieri D, Fitzgerald D, Shreeve SM, Hua E, Bronder JL, Weil RJ, Davis S, Stark AM, Merino MJ, Kurek R, Mehdorn HM, Davis G, Steinberg SM, Meltzer PS, Aldape K, Steeg PS. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of Hexokinase 2 and poor prognosis. Mol Cancer Res 7:1438-1445, 2009. PMCID: PMC2746883


Pandey M, Gupta S. Green tea and prostate cancer: from bench to clinic. Front Biosci (Elite Ed) 1:13-25, 2009.


Pant S, Hamadani M, Dodds AJ, Szer J, Crilley PA, Stevenson D, Phillips G, Elder P, Nivison-Smith I, Avalos BR, Penza S, Topolsky D, Sobecks R,Kalaycio MBolwell BJCopelan EA. Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukemia. Br J Haematol 148:623-626, 2009.


Park DM, Rich JN. Biology of glioma cancer stem cells. Mol Cells 28:7-12, 2009.


Park JW, Mieyal JJ, Rhee SG, Chock PB. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin. J Biol Chem 284:23364-23374, 2009.


Patel AR, Campbell SC. Current trends in the management of bladder cancer. J Wound Ostomy Continence Nurs 36:413-421, 2009.


Patel AR, Klein EA. Risk factors for prostate cancer. Nat Clin Pract Urol 6:87-95, 2009.


Patel NR, Rollison DE, Barnholtz-Sloan J, Mackinnon J, Green L, Giuliano AR. Racial and ethnic disparities in the incidence of invasive cervical cancer in Florida. Cancer 115:3991-4000, 2009.


Patel SR. Reduced sleep as an obesity risk factor. Obes Rev 10 Suppl 2:61-68, 2009.


Patel SR, Zhu X, Storfer-Isser A, Mehra R, Jenny NS, Tracy R, Redline S. Sleep duration and biomarkers of inflammation. Sleep 32:200-204, 2009. PMCID: PMC2635584


Pattanaik P, Bethel CR, Hujer AM, Hujer KM, Distler AM, Taracila M, Anderson VE, Fritsche TR, Jones RN, Pagadala SR, van den Akker F, Buynak JD, Bonomo RA. Strategic design of an effective beta-lactamase inhibitor: LN-1-255, A 6-alkylidene-2'-substituted penicillin sulfone. J Biol Chem 284:945-953, 2009. PMCID: PMC2613614


Pavlidakey PG, Maclennan GT. Radiation cystitis. J Urol 182:1172-1173, 2009.


Peetla C, Labhasetwar V. Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir 25:2369-2377, 2009. PMCID: PMC2653596


Peetla C, Rao KS, Labhasetwar V. Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles. Mol Pharm 6:1311-1320, 2009. PMCID: 2757462


Peetla C, Stine A, Labhasetwar V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol Pharm 6:1264-1276, 2009. PMCID: 2757518


Pennell NA, Lynch TJ Jr. Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC. Oncologist 14:399-411, 2009.


Pennell NAMekhail T. Investigational agents in the management of non-small cell lung cancer. Curr Oncol Rep 11:275-284, 2009.


Perrine CL, Ganguli A, Wu P, Bertozzi CR, Fritz TA, Raman J, Tabak LA, Gerken TA. The glycopeptide preferring polypeptide- GalNAc transferase-10 (ppGalNAc T10), involved in mucin type-O-glycosylation, has a unique GalNAc-O-Ser/Thr binding site in its catalytic domain not found in ppGalNAc T1 or T2. J Biol Chem 284:20387-20397, 2009.


Peters GA, Seachrist DD, Keri RASen GC. The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation. Proc Natl Acad Sci U S A 106:10696-10701, 2009. PMCID: PMC2705576


Petrelli NJ, Winer EP, Brahmer J, Dubey S, Smith S, Thomas C, Vahdat LT, Obel J, Vogelzang N, Markman M, Sweetenham JW, Pfister D, Kris MG, Schuchter LM, Sawaya R, Raghavan D, Ganz PA, Kramer B. Clinical Cancer Advances 2009: Major research advances in cancer treatment, prevention, and screening--A Report From the American Society of Clinical Oncology. J Clin Oncol 27:6052-6069, 2009.


Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, O'Reilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J, Tepper J. Consensus report of the National Cancer Institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol 27:5660-5669, 2009.


Phillips LS, Millikan RC, Schroeder JC, Barnholtz-Sloan JS, Levine BJ. Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 18:1507-1514, 2009.


Phillips LS, Thompson CL, Merkulova A, Plummer SJ, Tucker TC, Casey G, Li L. No association between phosphatase and tensin homolog genetic polymorphisms and colon cancer. World J Gastroenterol 15:3771-3775, 2009. PMCID: PMC2726455


Pieper U, Chiang R, Seffernick JJ, Brown SD, Glasner ME, Kelly L, Eswar N, Sauder JM, Bonanno JB, Swaminathan S, Burley SK, Zheng X, Chance MR, Almo SC, Gerlt JA, Raushel FM, Jacobson MP, Babbitt PC, Sali A. Target selection and annotation for the structural genomics of the amidohydrolase and enolase superfamilies. J Struct Funct Genomics 10:107-125, 2009. PMCID: PMC2693957


Platz EA, Till C, Goodman PJ, Parnes HL, Figg WD, Albanes D, Neuhouser ML, Klein EA, Thompson IM Jr, Kristal AR. Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 18:2807-2813, 2009.


Plow EF, Das R. Enolase-1 as a plasminogen receptor. Blood 113:5371-5372, 2009.


Plow EFQin JByzova T. Kindling the flame of integrin activation and function with kindlins. Curr Opin Hematol 16:323-328, 2009.


Poggio ED, Fairchild RL. Breaking down donor-reactive T-cell activation to two steps. Am J Transplant 9:2651-2652, 2009.


Pollack SM, Steinberg SM, Odom J, Dean RM, Fowler DH, Bishop MR. Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15:223-230, 2009.


Ponsky LE, Steinway ML, Lengu IJ, Hartke DM, Vourganti S, Cherullo EE. A Pfannenstiel single-site nephrectomy and nephroureterectomy: A practical application of laparoendoscopic single-site surgery. Urology 74:482-485, 2009.


Portier BP, Hansel DE, Zhou M, Maclennan GT. Mixed epithelial and stromal tumor of the kidney. J Urol 181:1879-1880, 2009.


Portillo JA, Okenka G, Kern TS, Subauste CS. Identification of primary retinal cells and ex vivo detection of proinflammatory molecules using flow cytometry. Mol Vis 15:1383-1389, 2009. PMCID: 2713733


Previs SF, Brunengraber DZ, Brunengraber H. Is there glucose production outside of the liver and kidney? Annu Rev Nutr 29:43-57, 2009.


Prince-Paul M. When hospice is the best option: an opportunity to redefine goals. Oncology (Williston Park) 23(4 Suppl):13-17, 2009.


Puchalski C, Ferrell B, Virani R, Otis-Green S, Baird P, Bull J, Chochinov H, Handzo G, Nelson-Becker H, Prince-Paul M, Pugliese K, Sulmasy D. Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference. J Palliat Med 12:885-904, 2009.

Qi JH, Dai G, Luthert P, Chaurasia S, Hollyfield J, Weber BH, Stoehr H, Anand-Apte B. S156C-mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis. J Biol Chem 284:19927-19936, 2009. PMCID: PMC2740418


Qian CN, Furge KA, Knol J, Huang D, Chen J, Dykema KJ, Kort EJ, Massie A, Khoo SK, Vanden Beldt K, Resau JH, Anema J, Kahnoski RJ, Morreau H, Camparo P, Comperat E, Sibony M, Denoux Y, Molinie V, Vieillefond A, Eng C, Williams BO, Teh BT. Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: Identification in human tumors and confirmation in animal models. Cancer Res 69:8256-8264, 2009. PMCID: PMC2783739


Quinn JA, Jiang SX, Carter J, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE 2nd, Threatt S, Friedman HS. Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme. Clin Cancer Res 15:1064-1068, 2009.


Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon Jr JE, Walker A, Friedman HS. Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma. Neuro Oncol 11:556-561, 2009. PMCID: 2765345


Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE 2nd, Walker A, Friedman HS. Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. J Clin Oncol 27:1262-1267, 2009.


Quintanilla-Martinez L, Slotta-Huspenina J, Koch I, Klier M, Hsi ED, de Leval L, Klapper W, Gesk S, Siebert R, Fend F. Differential diagnosis of cyclin D2+ mantle cell lymphoma (MCL) based on fluorescence in situ hybridization (FISH) and quantitative real-time-PCR. Haematologica 94:1595-1598, 2009. PMCID: 2770971


Quiogue G, Saggu S, Hung HI, Kenney MEOleinick NL, Lemasters JJ, Nieminen AL. Signaling from lysosomes enhances mitochondria-mediated photodynamic therapy In cancer cells. Proc Soc Photo Opt Instrum Eng 7380:1-8, 2009.

Radziewicz RM, Rose JHBowman KF, Berila RA, O'Toole EE, Given B. Establishing treatment fidelity in a coping and communication support telephone intervention for aging patients with advanced cancer and their family caregivers. Cancer Nurs 32:193-202, 2009.


Raedler H, Yang M, Lalli PN, Medof ME, Heeger PS. Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am J Transplant 9:1784-1795, 2009.


Raghavan D. Controversies in the management of localized prostate cancer: after the rhetoric. Oncology (Williston Park) 23:833-835, 2009.


Ramesh S, Wildey GM, Howe PH. Transforming growth factor beta (TGFbeta)-induced apoptosis: the rise and fall of Bim. Cell Cycle 8:11-17, 2009.


Ramirez LY, Huestis SE, Yap TY, Zyzanski SDrotar DKodish E. Potential chemotherapy side effects: what do oncologists tell parents? Pediatr Blood Cancer 52:497-502, 2009. PMCID: PMC2643320


Rani MR, Xu Y, Lee JC, Shrock J, Josyula A, Schlaak J, Chakraborthy S, Ja N, Ransohoff RM, Rudick RA. Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta. Ann N Y Acad Sci 1182:58-68, 2009.


Ransohoff RM. Chemokines and chemokine receptors: Standing at the crossroads of immunobiology and neurobiology. Immunity 31:711-721, 2009. PMCID: PMC2787682


Ransohoff RM. Immunology: In the beginning. Nature 462:41-42, 2009.


Ransohoff RM. Natalizumab, multiple sclerosis, and primary central nervous system lymphoma: Enigma, wrapped in mystery, enclosed in conundrum. Ann Neurol 66:259-261, 2009.


Rao KS, Ghorpade A, Labhasetwar V. Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv 6:771-784, 2009.


Rasmussen SB, Jensen SB, Nielsen C, Quartin E, Kato H, Chen ZJ, Silverman RH, Akira S, Paludan SR. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production. J Gen Virol 90:74-78, 2009.


Ray PS, Jia J, Yao P, Majumder M, Hatzoglou M, Fox PL. A stress-responsive RNA switch regulates VEGFA expression. Nature 457:915-919, 2009.


Read K, Fernandez CV, Gao J, Strahlendorf C, Moghrabi A, Pentz RD, Barfield RC, Baker JN, Santor D, Weijer C, Kodish E. Decision-making by adolescents and parents of children with cancer regarding health research participation. Pediatrics 124:959-965, 2009.


Reddy MK, Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J 23:1384-1395, 2009.


Reeves HM, Maclennan GT. Paratesticular rhabdomyosarcoma. J Urol 182:1578-1579, 2009.


Rege TA, Stewart J Jr, Dranka B, Benveniste EN, Silverstein RLGladson CL. Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1. J Cell Physiol 218:94-103, 2009. PMCID: PMC2597846


Reineke EL, Kao HY. PML: An emerging tumor suppressor and a target with therapeutic potential. Cancer Ther 7:219-226, 2009. PMCID: PMC2743178


Reineke EL, Kao HY. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies. Int J Biol Sci 5:366-376, 2009. PMCID: PMC2686094


Reineks EZ, Osei ES, Rosenberg A, Auletta JMeyerson HJ. CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells. Cytometry B Clin Cytom 76B:237-248, 2009.


Richendollar BG, Hsi ED, Cook JR. Extramedullary plasmacytoma-like posttransplantation lymphoproliferative disorders: clinical and pathologic features. Am J Clin Pathol 132:581-588, 2009.


Richendollar BG, Tsao RE, Elson P, Jin T, Steinle R, Pohlman BHsi ED. Predictors of outcome in post-transplant lymphoproliferative disorder: an evaluation of tumor infiltrating lymphocytes in the context of clinical factors. Leuk Lymphoma 50:2005-2012, 2009.


Ringdén O, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Gupta V, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, Marks DI, McCarthy PL, Cowan MJ, Petersdorf EW, Russell JA, Schiller GJ, Schouten H, Spellman S, Verdonck LF, Wingard JR, Horowitz MM, Arora M. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 113:3110-3118, 2009. PMCID: PMC2662650


Rini BI. Circulating tumor cells in metastatic castration-resistant prostate cancer. Curr Oncol Rep 11:163-164, 2009.


Rini BI. Metastatic renal cell carcinoma: many treatment options, one patient. J Clin Oncol 27:3225-3234, 2009.


Rini BI. Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma. Cancer 115:2306-2312, 2009.


Rini BI, Atkins MB. Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 10:992-1000, 2009.


Rini BICampbell SC, Escudier B. Renal cell carcinoma. Lancet 373:1119-1132, 2009.


Rini BIGarcia JACooney MMElson P, Tyler A, Beatty K, Bokar J, Mekhail TBukowski RMBudd GTTriozzi PBorden E, Ivy P, Chen HX, Dowlati A,Dreicer R. A phase I study of sunitinib plus bevacizumab in advanced solid tumors. Clin Cancer Res 15:6277-6283, 2009. PMCID: PMC2756318


Rini BI, Wilding G, Hudes G, Stadler WM, Kim S, Tarazi J, Rosbrook B, Trask PC, Wood L, Dutcher JP. Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma. J Clin Oncol 27:4462-4468, 2009.


Rodriguez ME, Zhang P, Azizuddin K, Delos Santos GB, Chiu SM, Xue LY, Berlin JC, Peng X, Wu H, Lam M, Nieminen AL, Kenney MEOleinick NL. Structural factors and mechanisms underlying the improved photodynamic cell killing with silicon phthalocyanine photosensitizers directed to lysosomes versus mitochondria. Photochem Photobiol 85:1189-1200, 2009.


Rong YP, Barr P, Yee VCDistelhorst CW. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. Biochim Biophys Acta 1793:971-978, 2009.


Rong YP, Bultynck G, Aromolaran AS, Zhong F, Parys JB, De Smedt H, Mignery GA, Roderick HL, Bootman MD, Distelhorst CW. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci U S A 106:14397-14402, 2009. PMCID: 2728114


Rosca MG, Lemieux H, Hoppel CL. Mitochondria in the elderly: is acetylcarnitine a rejuvenator? Adv Drug Deliv Rev 61:1332-1342, 2009.


Rose JHBowman KF, Radziewicz RM, Lewis SA, O'Toole EE. Predictors of engagement in a coping and communication support intervention for older patients with advanced cancer. J Am Geriatr Soc 57 Suppl 2:S296-299, 2009.


Rose JH, Kypriotakis G, Bowman KF, Einstadter D, O'Toole EE, Mechekano R, Dawson NV. Patterns of adaptation in patients living long term with advanced cancer. Cancer 115:4298-4310, 2009.


Rose JH, O'Toole EE, Koroukian S, Berger NA. Geriatric oncology and primary care: promoting partnerships in practice and research. J Am Geriatr Soc 57 Suppl 2:S235-238, 2009.


Rosenberg LA, Prayson RA, Lee J, Reddy C, Chao STBarnett GHVogelbaum MA, Suh JH. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys 74:427-432, 2009.


Rosenblum JM, Zhang QW, Siu G, Collins TL, Sullivan T, Dairaghi DJ, Medina JC, Fairchild RL. CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival. Transplantation 87:360-369, 2009.


Roy D, Steyer GJ, Gargesha M, Stone ME, Wilson DL. 3D cryo-imaging: a very high-resolution view of the whole mouse. Anat Rec (Hoboken) 292:342-351, 2009. PMCID: 2747656


Rozenblatt-Rosen O, Nagaike T, Francis JM, Kaneko S, Glatt KA, Hughes CM, LaFramboise T, Manley JL, Meyerson M. The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors. Proc Natl Acad Sci U S A 106:755-760, 2009. PMCID: PMC2615665


Ruhe MC, Carter C, Litaker DStange KC. A systematic approach to practice assessment and quality improvement intervention tailoring. Qual Manag Health Care 18:268-277, 2009.


Sa G, Das T, Moon C, Hilston CM, Rayman PA, Rini BITannenbaum CSFinke JH. GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells. Cancer Res 69:3095-3104, 2009. PMCID: PMC2728031


Sachdeva MP, Goldblum JR, Rubin BP, Billings SD. Low-fat and fat-free pleomorphic lipomas: a diagnostic challenge. Am J Dermatopathol 31:423-426, 2009.


Salem N, Kuang Y, Wang F, Maclennan GTLee Z. PET imaging of hepatocellular carcinoma with 2-deoxy-2[(18)F]fluoro-D-glucose, 6-deoxy-6[(18)F]fluoro-D-glucose, [(1-11)C]-acetate and [N-methyl-(11)C]-choline. Q J Nucl Med Mol Imaging 53:144-156, 2009.


Sammalisto S, Hiekkalinna T, Schwander K, Kardia S, Weder AB, Rodriguez BL, Doria A, Kelly JA, Bruner GR, Harley JB, Redline S, Larkin EK, Patel SR, Ewan AJ, Weber JL, Perola M, Peltonen L. Genome-wide linkage screen for stature and body mass index in 3.032 families: evidence for sex- and population-specific genetic effects. Eur J Hum Genet 17:258-266, 2009. PMCID: PMC2628452


Sanborn SL, Gibbons JKrishnamurthi S, Brell JMDowlati ABokar JANock C, Horvath N, Bako J, Remick SC, Cooney MM. Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors. Invest New Drugs 27:453-460, 2009.


Sanborn SL, Maclennan GCooney MM, Zhou M, Ponsky LE. High-grade transitional cell carcinoma and melanosis of urinary bladder: case report and review of the literature. Urology 73:928.e13-928.e15, 2009.


Sarkar D, Yang JC, Gupta AS, Lopina ST. Synthesis and characterization of L-tyrosine based polyurethanes for biomaterial applications. J Biomed Mater Res A 90:263-271, 2009.


Sawyer MD, Cherullo EE, Elmunzer BJ, Schomisch S, Ponsky LE. Pure natural orifice Translumenal endoscopic surgery partial cystectomy: intravesical transurethral and extravesical transgastric techniques in a porcine model. Urology 74:1049-1053, 2009.


Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, Repici A, Sturm A, Malesci A, Panes J, Yla-Herttuala S, Fiocchi C, Danese S. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 136:585-595, 2009.


Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D, Heller G. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol 10:233-239, 2009.


Scher MS, Loparo KA. Neonatal EEG/sleep state analyses: a complex phenotype of developmental neural plasticity. Dev Neurosci 31:259-275, 2009.


Scher MS, Ludington-Hoe S, Kaffashi F, Johnson MW, Holditch-Davis D, Loparo KA. Neurophysiologic assessment of brain maturation after an 8-week trial of skin-to-skin contact on preterm infants. Clin Neurophysiol 120:1812-1818, 2009.


Schilling SH, Hjelmeland AB, Radiloff DR, Liu IM, Wakeman TP, Fielhauer JR, Foster EH, Lathia JD, Rich JN, Wang XF, Datto MB. NDRG4 is required for cell cycle progression and survival in glioblastoma cells. J Biol Chem 284:25160-25169, 2009.


Schnetz MP, Bartels CF, Shastri K, Balasubramanian D, Zentner GE, Balaji R, Zhang X, Song L, Wang ZLaframboise T, Crawford GE, Scacheri PC. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res 19:590-601, 2009. PMCID: PMC2665778


Schwandt A, Garcia JA. Complications of androgen deprivation therapy in prostate cancer. Curr Opin Urol 19:322-326, 2009.


Scott JG, Scott RG, Miller WL, Stange KC, Crabtree BF. Healing relationships and the existential philosophy of Martin Buber. Philos Ethics Humanit Med 4:11, 2009. PMCID: PMC2733137


Sekandi JN, Neuhauser D, Smyth K, Whalen CC. Active case finding of undetected tuberculosis among chronic coughers in a slum setting in Kampala, Uganda. Int J Tuberc Lung Dis 13:508-513, 2009.


Sekeres MA. REVelation (del: 5q). Blood 113:3888-3889, 2009.


Sekeres MA. Treatment of MDS: something old, something new, something borrowed... Hematology Am Soc Hematol Educ Program 656-663, 2009.


Sekeres MA. What my patients taught me about love. J Clin Oncol 27:4817-4818, 2009.


Sekeres MA, Elson P, Kalaycio ME, Advani AS, Copelan EA, Faderl S, Kantarjian HM, Estey E. Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood 113:28-36, 2009. PMCID: PMC2614639


Sekeres MA, Steensma DP. Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease - implications for clinical trial design and enrollment. Blood 114:2575-2580, 2009. PMCID: 2756119


Sereti I, Dunham RM, Spritzler J, Aga E, Proschan MA, Medvik K, Battaglia CA, Landay AL, Pahwa S, Fischl MA, Asmuth DM, Tenorio AR, Altman JD, Fox L, Moir S, Malaspina A, Morre M, Buffet R, Silvestri G, Lederman MM; ACTG 5214 Study Team. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 113:6304-6314, 2009. PMCID: 2710926


Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 360:2277-2288, 2009.


Shaheen PE, Walsh D, Lasheen W, Davis MP, Lagman RL. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manage 38:409-417, 2009.


Shariat SF, Kattan MW, Vickers AJ, Karakiewicz PI, Scardino PT. Critical review of prostate cancer predictive tools. Future Oncol 5:1555-1584, 2009.


Sharma P, Falk GW, Sampliner R, Jon Spechler S, Wang K. Management of nondysplastic Barrett's esophagus: where are we now? Am J Gastroenterol 104:805-808, 2009.


Shelton MD, Distler AM, Kern TS, Mieyal JJ. Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (muller) cells. J Biol Chem 284:4760-4766, 2009. PMCID: PMC2643491


Shen GQ, Abdullah KG, Wang QK. The TaqMan Method for SNP genotyping. Methods Mol Biol 578:293-306, 2009.


Shepard DR, Dreicer RGarcia JElson P, Magi-Galluzzi C, Raghavan DStephenson AJKlein EA. Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy. J Urol 181:1672-1677, 2009.


Shepard DR, Garcia JA. Toxicity associated with the long-term use of targeted therapies in patients with advanced renal cell carcinoma. Expert Rev Anticancer Ther 9:795-805, 2009.


Sheth DB, Diefes R, Gratzl M. Spatially averaging electrodes. Anal Chem 81:2129–2134, 2009.


Shi H, Akunuru S, Bierman JC, Hodge KM, Mitchell MC, Foster MT, Seeley RJ, Reizes O. Diet-induced obese mice are leptin insufficient after weight reduction. Obesity (Silver Spring) 17:1702-1709, 2009.


Shi JF, Belinson JL, Zhao FH, Pretorius RG, Li J, Ma JF, Chen F, Xiang W, Pan QJ, Zhang X, Zhang WH, Qiao YL, Smith JS. Human papillomavirus testing for cervical cancer screening: results From a 6-year prospective study in rural China. Am J Epidemiol 170:708-716, 2009.


Shukla S, Gupta S. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study. Mol Carcinog 48:243-252, 2009. PMCID: PMC2647985


Shukla S, Shukla M, Maclennan GTFu PGupta S. Deregulation of FOXO3A during prostate cancer progression. Int J Oncol 34:1613-1620, 2009. PMCID: PMC2683383


Shultz DB, Rani MR, Fuller JD, Ransohoff RM, Stark GR. Roles of IKK-beta, IRF1, and p65 in the activation of chemokine genes by interferon-gamma. J Interferon Cytokine Res 29:817-824, 2009.


Sikand K, Slane SD, Shukla GC. Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells. Cancer Cell Int 9:21, 2009. PMCID: 2739157


Silverstein RL. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med 76(Suppl 2):S27-S30, 2009.


Silverstein RL. Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress. Clin Lipidol 4:767, 2009. PMCID: PMC2819200


Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2:re3, 2009.


Simmons MN, Klein EA. Combined androgen blockade revisited: emerging options for the treatment of castration-resistant prostate cancer. Urology 73:697-705, 2009.


Simon DI, Parikh SA. Hunting for the "sweet spot" in P2Y12 receptor blockade. J Am Coll Cardiol 54:1447-1449, 2009.


Simunovic M, Rempel E, Thériault ME, Baxter NN, Virnig BA, Meropol NJ, Levine MN. Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg 52:E79-E86, 2009. PMCID: 2724831


Singh AD, Tubbs R, Biscotti C, Schoenfield L, Trizzoi P. Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma. Arch Pathol Lab Med 133:1223-1227, 2009.


Singh J, Padgett RA. Rates of in situ transcription and splicing in large human genes. Nat Struct Mol Biol 16:1128-1133, 2009.


Singh N, Das D, Singh A, Mohan ML. Prion protein and metal interaction: Physiological and pathological implications. Curr Issues Mol Biol 12:99-108, 2009.


Sinha R, Igo RP Jr, Saini SK, Elston RC, Luo Y. Bayesian intervals for linkage locations. Genet Epidemiol 33:604-616, 2009. PMCID: 2766027


Slavin TP, Wiesner GL. Developmental defects and childhood cancer. Curr Opin Pediatr 21:717-723, 2009.


Sloan AE, Nock CJ, Einstein DB. Diagnosis and treatment of melanoma brain metastasis: a literature review. Cancer Control 16:248-255, 2009.


Slyfield CR Jr, Niemeyer KE, Tkachenko EV, Tomlinson RE, Steyer GG, Patthanacharoenphon CG, Kazakia GJ, Wilson DL, Hernandez CJ. Three-dimensional surface texture visual ization of bone tissue through epifluorescence-based serial block face imaging. J Microsc 236:52-59, 2009.


Smith AK, Hansel DEKlein EA. Epidermoid cyst of the testicle. Urology 74:544, 2009.


Smith MA, Casadesus G. Walking toward a convergence in aging research. Front Neurosci 3:1, 2009. PMCID: PMC2695381


Smith SD, Bolwell BJAdvani AS, Andresen SW, Chan JL, Dean RMHsi EDKalaycio MEPohlman BL, Rybicki LA, Sweetenham JW. High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma. Leuk Lymphoma 4:1-7, 2009.


Smith SD, Sweetenham JW. Studying survival in hodgkin's lymphoma: All for one, or one for all? Why methodology matters. Oncologist 14:814-815, 2009.


Smyth KA. Current practices and perspectives on breast cancer screening and treatment in older women with dementia. J Am Geriatr Soc 57 Suppl 2:S272-274, 2009.


Soares EA, Santos AF, Gonzalez LM, Lalonde MS, Tebit DM, Tanuri A, Arts EJ, Soares MA. Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantage. J Antimicrob Chemother 64:938-944, 2009.


Solares CA, Wood B, Rodriguez CP, Lorenz RR, Scharpf J, Saxton J, Rybicki LA, Strome M, Esclamado R, Lavertu PAdelstein DJ. Does vocal cord fixation preclude nonsurgical management of laryngeal cancer? Laryngoscope 119:1130-1134, 2009.


Somanath PR, Byzova TV. 14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly. J Cell Physiol 218:394-404, 2009.


Somanath PR, Ciocea A, Byzova TV. Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys 53:53-64, 2009.


Somanath PR, Malinin NL, Byzova TV. Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis 12:177-185, 2009.


Somanath PR, Vijai J, Kichina JV, Byzova T, Kandel ES. The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt. Oncogene 28:2365-2369, 2009.


Sos ML, Michel K, Zander T, Weiss J, Frommolt P, Peifer M, Li D, Ullrich R, Koker M, Fischer F, Shimamura T, Rauh D, Mermel C, Fischer S, Stückrath I, Heynck S, Beroukhim R, Lin W, Winckler W, Shah K, LaFramboise T, Moriarty WF, Hanna M, Tolosi L, Rahnenführer J, Verhaak R, Chiang D, Getz G, Hellmich M, Wolf J, Girard L, Peyton M, Weir BA, Chen TH, Greulich H, Barretina J, Shapiro GI, Garraway LA, Gazdar AF, Minna JD, Meyerson M, Wong KK, Thomas RK. Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest 119:1727-1740, 2009. PMCID: PMC2689116


Sossey-Alaoui K, Bialkowska K, Plow EF. The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. J Biol Chem 284:33019-33029, 2009. PMCID: PMC2785142


Spies N, Nielsen CB, Padgett RA, Burge CB. Biased chromatin signatures around polyadenylation sites and exons. Mol Cell 36:245-254, 2009.


Spiotta AM, Bain MD, Lautzenheiser FK, Barnett GH. Neurological surgery at the Cleveland Clinic: a historical perspective. Neurosurgery 64:164-170, 2009.


Spring-Robinson C, Chandramouli V, Schumann WC, Faulhaber PF, Wang Y, Wu C, Ismail-Beigi F, Muzic RF Jr. Uptake of 18F-labeled 6-fluoro-6-deoxy-D-glucose by skeletal muscle is responsive to insulin stimulation. J Nucl Med 50:912-919, 2009.


Srivastava JK, Gupta S. Extraction, characterization, stability and biological activity of flavonoids isolated from chamomile flowers. Mol Cell Pharmacol (Windsor Mill) 1:138-147, 2009. PMCID: PMC2809371


Srivastava JK, Pandey M, Gupta S. Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity. Life Sci 85:663-669, 2009.


Stange KC. A science of connectedness. Ann Fam Med 7:387-395, 2009. PMCID: PMC2746514


Stange KC. The complexity of and opportunity for screening in primary care. Ann Fam Med 7:2-3, 2009. PMCID: PMC2625840


Stange KC. The generalist approach. Ann Fam Med 7:198-203, 2009. PMCID: PMC2682975


Stange KC. Th problem of fragmentation and the need for integrative solutions. Ann Fam Med 7:100-103, 2009. PMCID: PMC2653966


Stange KC, Ferrer RL. The paradox of primary care. Ann Fam Med 7:293-299, 2009. PMCID: PMC2713149


Stange KC, Ferrer RL, Miller WL. Making sense of health care transformation as adaptive-renewal cycles. Ann Fam Med 7:484-487, 2009.


Stange KC, Phillips WR. Annals transitions. Ann Fam Med 7:292, 2009. PMCID: PMC2713161


Stanya KJ, Kao HY. New insights into the functions and regulation of the transcriptional corepressors SMRT and N-CoR. Cell Div 4:7, 2009.


Stein CM, Elston RC. Finding genes underlying human disease. Clin Genet 75:101-106, 2009.


Steinway ML, Lengu IJ, Cherullo EEPonsky LE. Laparoendoscopic Single-Site (LESS) nephrectomy through a pfannenstiel incision: Porcine model. J Endourol 23:1293-1296, 2009.


Step MMRose JHAlbert JM, Cheruvu VK, Siminoff LA. Modeling patient-centered communication: Oncologist relational communication and patient communication involvement in breast cancer adjuvant therapy decision-making. Patient Educ Couns 77:369-378, 2009. PMCID: PMC2787652


Step MM, Siminoff LA, Rose JH. Differences in oncologist communication across age groups and contributions to adjuvant decision outcomes. J Am Geriatr Soc 57 Suppl 2:S279-282, 2009.


Stephenson AJ. Current treatment options for clinical stage I seminoma. World J Urol 27:427-432, 2009.


Stephenson AJ, Jones JS, Hernandez AV, Ciezki JP, Gong MC, Klein EA. Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels. Eur Urol 55:610-616, 2009.


Stephenson AJKattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol 27:4300-4305, 2009.


Stephenson AJ, Klein EA. Surgical management of low-stage nonseminomatous germ cell testicular cancer. BJU Int 104:1362-1368, 2009.


Stephenson AJ, Wood DP, Kattan MWKlein EA, Scardino PT, Eastham JA, Carver BS. Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. J Urol 182:1357-1363, 2009.


Stern MZ, Gupta SK, Salmon-Divon M, Haham T, Barda O, Levi S, Wachtel C, Nilsen TW, Michaeli S. Multiple roles for polypyrimidine tract binding (PTB) proteins in trypanosome RNA metabolism. RNA 15:648-665, 2009. PMCID: PMC2661826


Steyer GJ, Roy D, Salvado O, Stone ME, Wilson DL. Cryo-Imaging of fluorescently-labeled single cells in a mouse. Proc Soc Photo Opt Instrum Eng 7262:72620W-72620W8, 2009. PMCID: PMC2743343


Steyer GJ, Roy D, Salvado O, Stone ME, Wilson DL. Removal of out-of-plane fluorescence for single cell visualization and quantification in cryo-Imaging. Ann Biomed Eng 37:1613-1628, 2009.


Stiff PJ, Bensinger W, Abidi MH, Gingrich R, Artz AS, Nademanee A, Hansen KS, Sobczak C, Cutler C, Bolwell B, Shore TB, Lazarus HM, Yeager AM, Lovelace W, Guo M, Dreiling L. Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors. Biol Blood Marrow Transplant 15:827-834, 2009.


Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol 27:4671-4678, 2009.


Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Shinohara K, Fearn PA, Kattan MW, Stock RG. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 73:341-346, 2009.


Strunk CJ, Platzbecker U, Thiede C, Schaich M, Illmer T, Kang Z, Leahy P, Li C, Xie X, Laughlin MJLazarus HM, Gerson SL, Bunting KD, Ehninger G, Tse W. Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics. Am J Hematol 84:308-309, 2009.


Su H, Gunter JH, de Vries M, Connor T, Wanyonyi S, Newell FS, Segal D, Molero JC, Reizes O, Prins JB, Hutley LJ, Walder K, Whitehead JP. Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity. Biochem Biophys Res Commun 386:351-355, 2009.


Subauste CS. CD40, autophagy and toxoplasma gondii. Mem Inst Oswaldo Cruz 104:267-272, 2009.


Subauste CS. CD40 and the immune response to parasitic infections. Semin Immunol 21:273-282, 2009. PMCID: 2758065


Subauste CS. Autophagy as an antimicrobial strategy. Expert Rev Anti Infect Ther 7:743-752, 2009.


Subauste CS. Autophagy in immunity against toxoplasma gondii. Curr Top Microbiol Immunol 335:251-265, 2009.


Subramanian VS, Stephenson AJ, Goldfarb DA, Fergany AF, Novick AC, Krishnamurthi V. Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi. Urology 74:154-159, 2009.


Sudbery I, Stalker J, Simpson JT, Keane T, Rust AG, Hurles ME, Walter K, Lynch D, Teboul L, Brown SD, Li H, Ning Z, Nadeau JH, Croniger CM, Durbin R, Adams DJ. Deep short-read sequencing of chromosome 17 from the mouse strains A/J and CAST/Ei identifies significant germline variation and candidate genes that regulate liver triglyceride levels. Genome Biol 10:R112, 2009.


Suh JH, Chao ST, Vogelbaum MA. Management of brain metastases. Curr Neurol Neurosci Rep 9:223-230, 2009.


Sun D, Xu H, Wijerathna SR, Dealwis C, Lee RE. Structure-based design, synthesis, and evaluation of 2'-(2-hydroxyethyl)-2'-deoxyadenosine and the 5'-diphosphate derivative as ribonucleotide reductase inhibitors. ChemMedChem 4:1649-1656, 2009.


Sun KH, Lee HG, Smith MA, Shah K. Direct and indirect roles of Cdk5 as an upstream regulator in the JNK cascade: Relevance to neurotoxic insults in Alzheimer's disease. Mol Biol Cell 20:4611-4619, 2009. PMCID: PMC2770948


Sun P, Nallar SC, Kalakonda S, Lindner DJ, Martin SS, Kalvakolanu DV. GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring. Oncogene 28:1339-1347, 2009. PMCID: PMC2662763


Sun S, Yan PS, Huang TH, Lin S. Identifying differentially methylated genes using mixed effect and generalized least square models. BMC Bioinformatics 10:404, 2009. PMCID: PMC2800121


Sundgren PC, Nagesh V, Elias A, Tsien C, Junck L, Gomez Hassan DM, Lawrence TS, Chenevert TL, Rogers L, McKeever P, Cao Y. Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy study. J Magn Reson Imaging 29:291-297, 2009. PMCID: PMC2679518


Sweetenham JW. Identifying new targets for cancer therapy: The dawn of personalized cancer treatment? Therapy 6:291-292, 2009.


Sweetenham JW. Review: stem cell transplantation for mantle cell lymphoma: not yet the standard of care. Clin Adv Hematol Oncol 7:323-324, 2009.


Sweetenham JW. Treatment of lymphoblastic lymphoma in adults. Oncology (Williston Park) 23:1015-1020, 2009. Sy MS. The saga of prion: to cut or not to cut. Cell Res 19:1039-1040, 2009.


Szpurka H, Gondek LP, Mohan SR, Hsi ED, Theil KS, Maciejewski JP. UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation. Leukemia 23:610-614, 2009.


Szymanski J, Wilson DLZhang GQ. MIMI: multimodality, multiresource, information integration environment for biomedical core facilities. J Digit Imaging 22:535-547, 2009.

Tan A, Gilligan T. Controversies in the management of early-stage germ cell tumors. Curr Oncol Rep 11:235-243, 2009.


Tan J, Mao G, Cui MZ, Lamb B, Sy MS, Xu X. Residues at P2-P1 positions of varepsilon- and zeta-cleavage sites are important in formation of beta-amyloid peptide. Neurobiol Dis 36:453-460, 2009.


Tanaka H, Yao MC. Palindromic gene amplification--an evolutionarily conserved role for DNA inverted repeats in the genome. Nat Rev Cancer 9:216-224, 2009.


Tanas MR, Sthapanachai C, Nonaka D, Melamed J, Oliveira AM, Erickson-Johnson MR, Rubin BP. Pseudosarcomatous fibroblastic/myofibroblastic proliferation in perinephric adipose tissue adjacent to renal cell carcinoma: a lesion mimicking well-differentiated liposarcoma. Mod Pathol 22:1196-1200, 2009.


Tang Z, Jiang S, Du R, Petri ET, El-Telbany A, Chan PS, Kijima T, Dietrich S, Matsui K, Kobayashi M, Sasada S, Okamoto N, Suzuki H, Kawahara K, Iwasaki T, Nakagawa K, Kawase I, Christensen JG, Hirashima T, Halmos B, Salgia R, Boggon TJ, Kern JAMa PC. Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity. Oncogene 28:518-533, 2009. PMCID: PMC2633425


Tao M, Scacheri PC, Marinis JM, Harhaj EW, Matesic LE, Abbott DW. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways. Curr Biol 19:1255-1263, 2009.


Tapryal N, Mukhopadhyay C, Das D, Fox PL, Mukhopadhyay CK. Reactive oxygen species regulate ceruloplasmin by a novel mRNA decay mechanism involving its 3'-untranslated region: implications in neurodegenerative diseases. J Biol Chem 284:1873-1883, 2009.


Tartakoff AM, Jaiswal P. Nuclear fusion and genome encounter during yeast zygote formation. Mol Biol Cell 20:2932-2942, 2009. PMCID: PMC2695800


Tcherepanova I, Starr A, Lackford B, Adams MD, Routy JP, Boulassel MR, Calderhead D, Healey D, Nicolette C. The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90. PLoS One 4:e5853, 2009. PMCID: PMC2689350


Tekkis PP, Cornish JA, Remzi FH, Tilney HS, Strong SA, Church JM, Lavery IC, Fazio VW. Measuring sexual and urinary outcomes in women after rectal cancer excision. Dis Colon Rectum 52:46-54, 2009.


Tendulkar RD, Chellman-Jeffers M, Rybicki LA, Rim A, Kotwal A, Macklis R, Obi BB. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer 115:1621-1630, 2009.


Tenorio AR, Spritzler J, Martinson J, Gichinga CN, Pollard RB, Lederman MM, Kalayjian RC, Landay AL. The effect of aging on T-regulatory cell frequency in HIV infection. Clin Immunol 130:298-303, 2009. PMCID: 2662473


Thaiyananthan NN, Jacono FJ 3rd, Patel SR, Kern JA, Stoller JK. Right-to-left anatomic shunt associated with a persistent left superior vena cava: the importance of injection site in demonstrating the shunt. Chest 1362:617-620, 2009.


Thomas AA, Herts BR, Campbell SC. Gonadal vein tumor thrombus in metastatic renal cell carcinoma. Urology 73:1229-1230, 2009.


Thomas AA, Rini BICampbell SC. Integration of surgery and systemic therapy in the management of metastatic renal cancer. Curr Urol Rep 10:35-41, 2009.


Thomas AA, Rini BI, Lane BR, Garcia JDreicer RKlein EA, Novick AC, Campbell SC. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. J Urol 181:518-523, 2009.


Thomas AA, Rini BIStephenson AJGarcia JA, Fergany A, Krishnamurthi V, Novick AC, Gill IS, Klein EA, Zhou M, Campbell SC. Surgical resection of renal cell carcinoma after targeted therapy. J Urol 182:881-886, 2009.


Thomas AA, Rosenblatt S, Wachterman J, Liao W, Moussa A, Ponsky LE, Jones JS. Prospective evaluation of prostate cancer risk in candidates for inguinal hernia repair. J Am Coll Surg 209:371-376, 2009.


Thomas AA, Stephenson AJCampbell SC, Jones JS, Hansel DE. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol 40:108-116, 2009.


Thompson CL, Plummer SJ, Acheson LS, Tucker TC, Casey G, Li L. Association of common genetic variants in SMAD7 and risk of colon cancer. Carcinogenesis 30:982-986, 2009. PMCID: PMC2691142


Thompson CL, Plummer SJ, Merkulova A, Cheng I, Tucker TC, Casey G, Li L. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. World J Gastroenterol 15:2240-2244, 2009. PMCID: PMC2682239


Thompson IM, Tangen CM, Goodman PJ, Lucia MS, Klein EA. Chemoprevention of prostate cancer. J Urol 182:499-507, 2009.


Thompson IM, Tangen CM, Klein EA. Is there a standard of care for pathologic stage T3 prostate cancer? J Clin Oncol 27:2898-2899, 2009.


Thompson JA, Kuzel T, Drucker BJ, Urba WJ, Bukowski RM. Safety and efficacy of PF-3512676 for the treatment of stage IV renal cell carcinoma: an open-label, multicenter phase I/II study. Clin Genitourin Cancer 7:E58-65, 2009.


Tian C, Markman M, Zaino R, Ozols RF, McGuire WP, Muggia FM, Rose PG, Spriggs D, Armstrong DK. CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study. Cancer 115:1395-1403, 2009. PMCID: 2743569


Tie F, Banerjee R, Stratton CA, Prasad-Sinha J, Stepanik V, Zlobin A, Diaz MO, Scacheri PC, Harte PJ. CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development 136:3131-3141, 2009. PMCID: PMC2730368


Tigno-Aranjuez JT, Lehmann PV, Tary-Lehmann M. Dissociated induction of cytotoxicity and DTH by CFA and CpG. J Immunother 32:389-398, 2009.


Tiu R, Yacoub H, Maciejewski J, Sila CA. Recurrent ischemic stroke in paroxysmal nocturnal hemoglobinuria: paroxysmal nocturnal hemoglobinuria or missed patent foramen ovale? J Stroke Cerebrovasc Dis 18:409-410, 2009.


Tiu RV, Gondek LP, O'Keefe CL, Huh J, Sekeres MAElson P, McDevitt MA, Wang XF, Levis MJ, Karp JE, Advani ASMaciejewski JP. New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia. J Clin Oncol 27:5219-26, 2009. PMCID: PMC2773477


Tkachenko EV, Slyfield CR, Tomlinson RE, Daggett JR, Wilson DL, Hernandez CJ. Voxel size and measures of individual resorption cavities in three-dimensional images of cancellous bone. Bone 45:487-492, 2009. PMCID: PMC2728288


Tong Y, Hota PK, Penachioni JY, Hamaneh MB, Kim S, Alviani R, Shen L, He H, Tempel W, Tamagnone L, Park HW, Buck M. Structure and function of the intracellular region of the plexin-B1 transmembrane receptor. J Biol Chem 284:35962-35972, 2009. PMCID: PMC2791024


Torgerson DG, Boyko AR, Hernandez RD, Indap A, Hu X, White TJ, Sninsky JJ, Cargill M, Adams MD, Bustamante CD, Clark AG. Evolutionary processes acting on candidate cis-regulatory regions in humans inferred from patterns of polymorphism and divergence. PLoS Genet. 5:e1000592, 2009. PMCID: PMC2714078


Towe TPO'Toole E, Engelhardt K, Nagaiah G, Berger NA. Changing healthcare practice for older adults with late-stage non-small cell lung cancer: practical considerations of targeted therapy in primary care and oncology. J Am Geriatr Soc 57 Suppl 2:S253-258, 2009.


Townsend AL, Ishler KJ, Bowman KFRose JH, Peak NJ. Health and well-being in older married female cancer survivors. J Am Geriatr Soc 57 Suppl 2:S286-288, 2009.


Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, Abraha A, Tebit DM, Zhao H, Avila S, Lobritz MA, McElrath MJ, Le Gall S, Mullins JI, Arts EJ. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog 5:e1000365, 2009. PMCID: PMC2659432


Tubbs R, Barlow WE, Budd GT, Swain E, Porter P, Gown A, Yeh IT, Sledge G, Shapiro C, Ingle J, Haskell C, Albain KS, Livingston R, Hayes DF. Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. J Clin Oncol 27:3881-3886, 2009. PMCID: PMC2734394


Tyler CV Jr, Rader E, Campbell JW, Zyzanski SJ, Panaite V. Geriatrician training in the care of elders with intellectual and other developmental disabilities. Gerontol Geriatr Educ 30:332-340, 2009.


Tyler CV Jr, Zyzanski SJ, Berkley M, Panaite V. Calcium supplement use by African American women. J Natl Med Assoc 101:588-592, 2009.

Umar N, Litaker D, Terris DD. Toward more sustainable health care quality improvement in developing countries: the "little steps" approach. Qual Manag Health Care 18:295-304, 2009.


Umar SA, Umar SA, MacLennan GT. Small cell carcinoma of the prostate. J Urol 181:838-839, 2009.


Undurti A, Huang Y, Lupica JA, Smith JD, Didonato JA, Hazen SL. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J Biol Chem 284:30825-30835, 2009.


Valadkhan S, Manley JL. The use of simple model systems to study spliceosomal catalysis. RNA 15:4-7, 2009. PMCID: PMC2612768


Valadkhan S, Mohammadi A, Jaladat Y, Geisler S. Protein-free small nuclear RNAs catalyze a two-step splicing reaction. Proc Natl Acad Sci U S A 106:11901-11906, 2009.


Valdagni R, Scardino PT, Denis L, Kattan MW. Predictive modeling in prostate cancer: a conference summary. Eur Urol 55:300-302, 2009.


van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R, Nelson G, Fay JW, Champlin RE, Lazarus HM, Vose JM, Hari PN. Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes. Biol Blood Marrow Transplant 15:554-563, 2009.


van den Bent MJ, Vogelbaum MA, Wen PY, Macdonald DR, Chang SM. End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria. J Clin Oncol 27:2905-2908, 2009. PMCID: PMC2702230


Vaziri SA, Grabowski DR, Hill J, Rybicki LR, Burk R, Bukowski RM, Ganapathi MK, Ganapathi R. Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independent. Anticancer Res 29:2961-2969, 2009.


Veazey RS, Ling B, Green LC, Ribka EP, Lifson JD, Piatak Jr M, Lederman MM, Mosier D, Offord R, Hartley O. Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge. J Infect Dis 199:1525-1527, 2009.


Vernon LT, Demko CAWhalen CCLederman MM, Toossi Z, Wu M, Han YW, Weinberg A. Characterizing traditionally defined periodontal disease in HIV+ adults. Community Dent Oral Epidemiol 37:427-437, 2009.


Vesole DH, Zhang L, Flomenberg N, Greipp PR, Lazarus HM. ECOG Myeloma and BMT Committees. A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97. Biol Blood Marrow Transplant 15:83-91, 2009.


Vickerman MB, Keith PA, McKay TL, Gedeon DJ, Watanabe M, Montano M, Karunamuni G, Kaiser PK, Sears JE, Ebrahem Q, Ribita D, Hylton AG,Parsons-Wingerter P. VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks. Anat Rec (Hoboken) 292:320-332, 2009.


Vickers AJ, Cronin AM, Kattan MW, Gonen M, Scardino PT, Milowsky MI, Dalbagni G, Bochner BH; for The International Bladder Cancer Nomogram Consortium. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer 115:5460-5469, 2009. PMCID: PMC2785133


Vicus D, Rosen B, Lubinski J, Domchek S, Kauff ND, Lynch HT, Isaacs C, Tung N, Sun P, Narod SA…Eng C…; Hereditary Ovarian Cancer Clinical Study Group. Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers. Gynecol Oncol 115:135-137, 2009.


Videtic GM, Gaspar LE, Aref AM, Germano IM, Goldsmith BJ, Imperato JP, Marcus KJ, McDermott MW, McDonald MW, Patchell RA, Robins HI, Rogers CL,Suh JH, Wolfson AH, Wippold FJ 2nd (Expert Panel on Radiation Oncology–Brain Metastases). American College of Radiology appropriateness criteria on multiple brain metastases. Int J Radiat Oncol Biol Phys 75:961-965, 2009.


Videtic GM, Reddy CA, Chao ST, Rice TW, Adelstein DJ, Barnett GHMekhail TMVogelbaum MASuh JH. Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the Radiation Therapy Oncology Group recursive partitioning analysis classification. Int J Radiat Oncol Biol Phys 75:1141-1147, 2009.


Vig HS, Armstrong J, Egleston BL, Mazar C, Toscano M, Bradbury AR, Daly MB, Meropol NJ. Cancer genetic risk assessment and referral patterns in primary care. Genet Test Mol Biomarkers 13:735-741, 2009.


Vogelbaum MA, Asher AL, Kondziolka D, Boulis NM, Selden NR, Hoh BL, Barker FG 2nd. Modern treatment of cerebral metastases: integrated medical learning(SM) at CNS 2007. J Neurooncol 93:89-105, 2009.


Vogelbaum MA, Berkey B, Peereboom D, Macdonald D, Giannini C, Suh JH, Jenkins R, Herman J, Brown P, Blumenthal DT, Biggs C, Schultz C, Mehta M. Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. Neuro Oncol 11:167-175, 2009. PMCID: PMC2718988


von Gruenigen VE, Gibbons HE, Kavanagh MB, Janata JW, Lerner E, Courneya KS. A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change. Health Qual Life Outcomes 7:17, 2009. PMCID: PMC2656477


von Gruenigen VE, Huang HQ, Gil KM, Gibbons HE, Monk BJ, Rose PG, Armstrong DK, Cella D, Wenzel L. Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials. Cancer 115:4857-4864, 2009. PMCID: 2761522


von Gruenigen VE, Hurd WW. Robotic gynecologic surgery. Obstet Gynecol 14:168, 2009.


Vricella GJ, Ponsky LE, Cadeddu JA. Ablative technologies for urologic cancers. Urol Clin North Am 36:163-178, 2009.


Vykhovanets EV, Shukla S, Maclennan GT, Vykhovanets OV, Bodner DR, Gupta S. Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation. Prostate 69:633-643, 2009. PMCID: PMC2669895

Wagner J, Kean T, Young R, Dennis JE, Caplan AI. Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 20:531-536, 2009.


Walbert T, Sloan AE, Cohen ML, Koubeissi MZ. Symptomatic neurocutaneous melanosis and Dandy-Walker malformation in an adult. J Clin Oncol 27:2886-2887, 2009.


Wald A, Narasimhan S, Nieves-Arriba L, Waggoner SE. Prolonged hypercalcemia following resection of dysgerminoma: a case report. Obstet Gynecol Int 2009:956935, 2009. PMCID: PMC2796217


Walker JL, Morrison A, DiSilvestro P, von Gruenigen VE; Gynecologic Oncology Group. A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study. Gynecol Oncol 112:78-84, 2009.


Walz J, Chun FK, Klein EA, Reuther A, Saad F, Graefen M, Huland H, Karakiewicz PI. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol 181:601-607, 2009.


Wan L, Sun K, Ding Q, Cui Y, Li M, Wen Y, Elston RC, Qian M, Fu WJ. Hybridization modeling of oligonucleotide SNP arrays for accurate DNA copy number estimation. Nucleic Acids Res 37:e117, 2009. PMCID: 2761258


Wan Y, Xiao H, Affolter J, Kim TW, Bulek K, Chaudhuri S, Carlson D, Hamilton T, Mazumder B, Stark GR, Thomas J, Li X. Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control. J Biol Chem 284:10367-10375, 2009. PMCID: PMC2667724


Wang C, O'Neill SM, Rothrock N, Gramling R, Sen A, Acheson LS, Rubinstein WS, Nease DE Jr, Ruffin MT 4th, Yoon PW, Valdez R, Irizarry-De La Cruz M, Khoury MJ, Jorgensen C, Scheuner MT, O'Neill S, Rubinstein WS, Rothrock N, Beaumont J, Khan S, Ali D, Cloherty E, Wang C, Ruffin MT, Nease DE Jr,Acheson LSZyzanski SJWiesner GLWerner J, Gramling R, Pace WD, Galliher JM, Brandt E.; for the Family Healthware™ Impact Trial (FHITr) group. Comparison of risk perceptions and beliefs across common chronic diseases. Prev Med 48:197-202, 2009. PMCID: PMC2720609


Wang F, Dennis JE, Awadallah A, Solchaga LA, Molter J, Kuang Y, Salem N, Lin Y, Tian H, Kolthammer JA, Kim Y, Love ZB, Gerson SLLee Z. Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging. Physiol Genomics 37:23-34, 2009. PMCID: PMC2661103


Wang F, Kuang Y, Salem N, Anderson PW, Lee Z. Cross-species hybridization of woodchuck hepatitis viral infection-induced woodchuck hepatocellular carcinoma using human, rat and mouse oligonucleotide microarrays. J Gastroenterol Hepatol 24:605-617, 2009.


Wang H, Lathia JD, Wu Q, Wang J, Li Z, Heddleston JM, Eyler CE, Elderbroom J, Gallagher J, Schuschu J, Macswords J, Cao Y, McLendon RE, Wang XF, Hjelmeland AB, Rich JN. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 27:2393-3404, 2009.


Wang H, Rollins AM. Speckle reduction in optical coherence tomography using angular compounding by B-scan Doppler-shift encoding. J Biomed Opt 14:030512, 2009.


Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA. Notch promotes radioresistance of glioma stem cells. Stem Cells 28:17-28, 2009.


Wang LW, Leonhard-Melief C, Haltiwanger RS, Apte SS. Post-translational modification of thrombospondin type-1 repeats in adamtsl1/punctin-1 by C-mannosylation of tryptophan. Chem 284:30004-30015, 2009. PMCID: PMC2781554


Wang S, Yu WM, Zhang W, McCrae KR, Neel BG, Qu CK. Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis. J Biol Chem 284:913-920, 2009. PMCID: PMC2613626


Wang T, Ho G, Ye K, Strickler H, Elston RC. A partial least-square approach for modeling gene-gene and gene-environment interactions when multiple markers are genotyped. Genet Epidemiol 33:6-15, 2009.


Wang X, Maclennan GT, Zhang S, Montironi R, Lopez-Beltran A, Tan PH, Foster S, Baldridge LA, Cheng L. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization. Hum Pathol 40:211-217, 2009.


Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 29:9090-9103, 2009.


Wang X, Su B, Zheng L, Perry G, Smith MA, Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Neurochem 109(Suppl 1):153-159, 2009. PMCID: PMC2720030


Wang X, Wang M, Maclennan GT, Abdul-Karim FW, Eble JN, Jones TD, Olobatuyi F, Eisenberg R, Cummings OW, Zhang S, Lopez-Beltran A, Montironi R, Zheng S, Lin H, Davidson DD, Cheng L. Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst 101:560-570, 2009.


Wang X, Zhang S, Maclennan GT, Biermann K, Foster RS, Beck SD, Cheng L. Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma. Mod Pathol 22:7-12, 2009.


Wang Y, Blozis SA, Lederman M, Krieg A, Landay A, Miller CJ. Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine. Clin Vaccine Immunol 16:499-505, 2009. PMCID: PMC2668268


Wang YLiu L, Wu C, Bulgar A, Somoza E, Zhu W, Gerson SL. Direct detection and quantification of abasic sites for in vivo studies of DNA damage and repair. Nucl Med Biol 36:975-983, 2009.


Wang Z. Epitope tagging of endogenous proteins for genome-wide chromatin immunoprecipitation analysis. Methods Mol Biol 567:87-98, 2009.


Wang Z, Li G, Tse W, Bunting KD. Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement. Blood 113:4856-4865, 2009. PMCID: PMC2686137


Warren CB, Karai LJ, Vidimos A, Maytin EV. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. J Am Acad Dermatol 61:1033-1043, 2009.


Weaver J, Goldblum JR, Turner S, Tubbs RR, Wang WL, Lazar AJ, Rubin BP. Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma. Mod Pathol 22:66-70, 2009.


Wei S, Chen X, Rocha K, Epling-Burnette PK, Djeu JY, Liu Q, Byrd J, Sokol L, Lawrence N, Pireddu R, Dewald G, Williams A, Maciejewski J, List A. A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide. Proc Natl Acad Sci U S A 106:12974-12979, 2009. PMCID: PMC2722346


Weight CJ, Garcia JAHansel DE, Fergany AF, Campbell SC, Gong MC, Jones JS, Klein EADreicer RStephenson AJ. Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series. Cancer 115:792-799, 2009.


Weinreb I, Shaw AJ, Perez-Ordoñez B, Goldblum JR, Rubin BP. Nodular fasciitis of the head and neck region: a clinicopathologic description in a series of 30 cases. J Cutan Pathol 36:1168-1173, 2009.


Weisdorf DJ, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH, Bolwell B, Cahn JY, Cervantes F, Copelan E, Gale R, Gratwohl A, Khoury HJ, McCarthy P, Marks DI, Szer J, Woolfrey A, Cortes-Franco J, Horowitz MM, Arora M; Chronic Leukemia Working Committee. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. Biol Blood Marrow Transplant 15:1475-1478, 2009.


Weiss MA. The structure and function of insulin: decoding the TR transition. Vitam Horm 80:33-49, 2009.


Weitzel RP, Lesniewski ML, Haviernik P, Kadereit S, Leahy P, Greco NJ, Laughlin MJ. MicroRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T-cells. Blood 113:6648-6657, 2009. PMCID: PMC2710921


Wesolowski R, Budd GT. Neoadjuvant therapy for breast cancer: assessing treatment progress and managing poor responders. Curr Oncol Rep 11:37-44, 2009.


Wikenheiser J, Wolfram JA, Gargesha M, Yang K, Karunamuni G, Wilson DL, Semenza GL, Agani F, Fisher SA, Ward N, Watanabe M. Altered hypoxia-inducible factor-1 alpha expression levels correlate with coronary vessel anomalies. Dev Dyn 238:2688-2700, 2009.


Wildey GM, Howe PH. Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells. J Biol Chem 284:20227-20239, 2009.


Williams PS, Carpino F, Zborowski M. Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation. Mol Pharm 6:1290-1306, 2009. PMCID: 2757515


Williams PS, Carpino F, Zborowski M. Theory for nanoparticle retention time in the helical channel of quadrupole magnetic field-flow fractionation. J Magn Magn Mater 321:1446-1451, 2009. PMCID: PMC2757298


Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, Demetri G, Ganz P, Kramer B, Kris M, Markman M, Mayer R, Pfister D, Raghavan D, Ramsey S, Reaman G, Sandler H, Sawaya R, Schuchter L, Sweetenham J, Vahdat L, Schilsky RL; American Society of Clinical Oncology. Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening–a report from the American Society of Clinical Oncology. J Clin Oncol 27:812-826, 2009. PMCID: PMC2645086


Won S, Kim S, Elston RC. Phase uncertainty in case-control association studies. Genet Epidemiol 33:463-478, 2009.


Won S, Morris N, Lu Q, Elston RC. Choosing an optimal method to combine P-values. Stat Med 28:1537-1553, 2009. PMCID: PMC2771157


Wong KK, Fracasso PM, Bukowski RM, Lynch TJ, Munster PN, Shapiro GI, Jänne PA, Eder JP, Naughton MJ, Ellis MJ, Jones SF, Mekhail T, Zacharchuk C, Vermette J, Abbas R, Quinn S, Powell C, Burris HA. A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors. Clin Cancer Res 15:2552-2558, 2009.


Wong YN, Meropol NJ, Speier W, Sargent D, Goldberg RM, Beck JR. Cost implications of new treatments for advanced colorectal cancer. Cancer 115: 2081-2091, 2009.


Wu H, Exner AA, Krupka TM, Weinberg BD, Haaga JR. Vasomodulation of tumor blood flow: effect on perfusion and thermal ablation size. Ann Biomed Eng 37:552-564, 2009.


Wu H, Exner AA, Krupka TM, Weinberg BD, Patel R, Haaga JR. Radiofrequency ablation: post-ablation assessment using CT perfusion with pharmacological modulation in a rat subcutaneous tumor model. Acad Radiol 16:321-331, 2009.


Wu H, Exner AA, Shi H, Bear J, Haaga JR. Dynamic evolutionary changes in blood flow measured by MDCT in a hepatic VX2 tumor implant over an extended 28-day growth period: time-density curve analysis. Acad Radiol 16:1483-1492, 2009.


Wu MF, Hilsenbeck SG, Tham YL, Kramer R, Elledge RM, Chang JC, Friedman LC. The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer. Breast Cancer Res Treat 118:369-375, 2009.


Wu Z, Gogonea V, Lee X, Wagner MA, Li XM, Huang Y, Undurti A, May RP, Haertlein M, Moulin M, Gutsche I, Zaccai G, Didonato JA, Hazen SL. Double super helix model of high density lipoprotein. J Biol Chem 284:36605-36619, 2009.

Xu B, Huang K, Chu YC, Hu SQ, Nakagawa S, Wang S, Wang RY, Whittaker J, Katsoyannis PG, Weiss MA. Decoding the cryptic active conformation of a protein by synthetic photoscanning: insulin inserts a detachable arm between receptor domains. J Biol Chem 284:14597-14608, 2009. PMCID: PMC2682907

Yan M, Myung SJ, Fink SP, Lawrence E, Lutterbaugh J, Yang P, Zhou X, Liu D, Rerko RM, Willis JDawson D, Tai HH, Barnholtz-Sloan JS, Newman RA, Bertagnolli MM, Markowitz SD. 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. Proc Natl Acad Sci U S A 106:9409-9413, 2009. PMCID: PMC2695050


Yan T, Seo Y, Kinsella TJ. Differential cellular responses to prolonged LDR-IR in MLH1-proficient and MLH1-deficient colorectal cancer HCT116 cells. Clin Cancer Res 15:6912-6920, 2009. PMCID: PMC2783277


Yang J, Kalhan SC, Hanson RW. What is the metabolic role of phosphoenolpyruvate carboxykinase? J Biol Chem 284:27025-27029, 2009.


Yang J, Kong X, Martins-Santos ME, Aleman G, Chaco E, Liu GE, Wu SY, Samols D, Hakimi P, Chiang CM, Hanson RW. Activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating hepatic nuclear factor 4alpha. J Biol Chem 284:27042-27053, 2009.


Yang J, Ma YQ, Page RC, Misra S, Plow EFQin J. Structure of an integrin alphaIIb beta3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation. Proc Natl Acad Sci U S A 106:17729-17734 , 2009. PMCID: 2764936


Yang J, Reshef L, Cassuto H, Aleman G, Hanson RW. II. Aspects of the control of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 284:27031-27035, 2009.


Yang J, Wahdan-Alaswad R, Danielpour D. Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells. Cancer Res 69:2185-2190, 2009.


Yang K, Doughman YQ, Karunamuni G, Gu S, Yang YC, Bader DM, Watanabe M. Expression of active Notch1 in avian coronary development. Dev Dyn 238:162-170, 2009.


Yang L, Lang JC, Balasubramanian P, Jatana KR, Schuller D, Agrawal A, Zborowski M, Chalmers JJ. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng 102:521-534, 2009.


Yang Q, Fang Y, Sun CK, Siemionow V, Ranganathan VK, Khoshknabi D, Davis MP, Walsh D, Sahgal V, Yue GH. Weakening of functional corticomuscular coupling during muscle fatigue. Brain Res 1250:101-112, 2009. PMCID: PMC2655124


Yang Y, Wang X, Hawkins CA, Chen K, Vaynberg J, Mao X, Tu Y, Zuo X, Wang J, Wang YX, Wu C, Tjandra N, Qin J. Structural basis of focal adhesion localization of LIM-only adaptor PINCH by integrin-linked kinase. J Biol Chem 284:5836-5844, 2009. PMCID: PMC2645833


Yap TY, Yamokoski A, Noll R, Drotar DZyzanski SKodish ED; Multi-site Intervention Study to Improve Consent Research Team. A physician-directed intervention: teaching and measuring better informed consent. Acad Med 84:1036-1042, 2009.


Yavas G, Koyuturk M, Ozsoyoglu M, Gould M, Laframboise T. An optimization framework for unsupervised identification of rare copy number variation from SNP array data. Genome Biol 10:R119, 2009.


Yavuzsen T, Davis MP, Ranganathan VK, Walsh D, Siemionow V, Kirkova J, Khoshknabi D, Lagman R, Legrand S, Yue GH. Cancer-related fatigue: central or peripheral? ? J Pain Symptom Manage 38:587-596, 2009.


Yavuzsen T, Walsh D, Davis MP, Kirkova J, Jin T, Legrand S, Lagman R, Bicanovsky L, Estfan B, Cheema B, Haddad A. Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 17:1531-1541, 2009.


Ye Y, McDevitt MA, Guo M, Zhang W, Galm O, Gore SD, Karp JE, Maciejewski JP, Kowalski J, Tsai HL, Gondek LP, Tsai HC, Wang X, Hooker C, Smith BD, Carraway HE, Herman JG. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies. Cancer Res 69:8482-8490., 2009.


Yonkers NL, Milkovich KA, Rodriguez B, Post AB, Asaad R, Heinzel FP, Valdez H, Tary-Lehmann MAnthony DD. Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection. Clin Immunol 131:288-297, 2009.


Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Willson JK, Markowitz S, Zhou S, Diaz LA Jr, Velculescu V, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325:1555-1559, 2009.

Zaky SS, Barnett GH, Abd-Elsayed AA, Farag E. Coronary artery spasm associated with blood brain barrier disruption induced by carotid sinus stimulation. Minerva Anestesiol 75:1-4, 2009.


Zerikly RK, Eray E, Faiman C, Prayson R, Lorenz RR, Weil RJ, Hamrahian AH. Cyclic Cushing syndrome due to an ectopic pituitary adenoma. Nat Clin Pract Endocrinol Metab 5:174-179, 2009.


Zhang GF, Kombu RS, Kasumov T, Han Y, Sadhukhan S, Zhang J, Sayre LM, Ray D, Gibson KM, Anderson VA, Tochtrop GP, Brunengraber H. Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-COAs. J Biol Chem 284:33521-33534, 2009. PMCID: PMC2785196


Zhang H, Stavnezer E. Ski regulates muscle terminal differentiation by transcriptional activation of myog in a complex with six1 and eya3. J Biol Chem 284:2867-2879, 2009. PMCID: PMC2631951


Zhang JP, Kahana B, Kahana E, Hu B, Pozuelo L. Joint modeling of longitudinal changes in depressive symptoms and mortality in a sample of community-dwelling elderly people. Psychosom Med 71:704-714, 2009.


Zhang P, Becka S, Craig SE, Lodowski DT, Brady-Kalnay SMWang Z. Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation. Cell Commun Adhes 16:146-153, 2009.


Zhang P, Lathia JD, Flavahan WA, Rich JN, Mattson MP. Squelching glioblastoma stem cells by targeting REST for proteasomal degradation. Trends Neurosci 32:559-565, 2009. PMCID: 2767465


Zhang WX, Frahm G, Morley S, Manor D, Atkinson J. Effect of bilayer phospholipid composition and curvature on ligand transfer by the alpha-tocopherol transfer protein. Lipids 44:631-641, 2009.


Zhang X, Dowd DR, Moore MC, Kranenburg TA, Meester-Smoor MA, Zwarthoff EC, Macdonald PN. Meningioma 1 (MN1) is required for appropriate osteoblast proliferation, motility, differentiation and function. J Biol Chem 284:18174-83, 2009. PMCID: PMC2709374


Zhang Y, Sieuwerts AM, McGreevy M, Casey G, Cufer T, Paradiso A, Harbeck N, Span PN, Hicks DG, Crowe J, Tubbs RR, Budd GT, Lyons J, Sweep FC, Schmitt M, Schittulli F, Golouh R, Talantov D, Wang Y, Foekens JA. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Breast Cancer Res Treat 116:303-309, 2009.


Zhao Y, Burda C. Chemical synthesis of bi(0.5)sb(1.5)te(3) nanocrystals and their surface oxidation properties. ACS Appl Mater Interfaces 1:1259-1263, 2009.


Zhao Y, Marotta M, Eichler EE, Eng CTanaka H. Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genes. PLoS Genet 5:e1000472, 2009. PMCID: PMC2672168


Zheng H, Alter S, Qu CK. SHP-2 tyrosine phosphatase in human diseases. Int J Clin Exp Med 2:17-25, 2009. PMCID: PMC2680053


Zheng L, Liu S, Sun MZ, Chang J, Chance MR, Kern TS. Pharmacologic intervention targeting glycolytic-related pathways protects against retinal injury due to ischemia and reperfusion. Proteomics 9:1869-1882, 2009.


Zhou EH, Ellis RJ, Cherullo E, Colussi V, Xu F, Chen WD, Gupta SWhalen CC, Bodner D, Resnick MIRimm AAKoroukian SM. Radiotherapy and survival in prostate cancer patients: a population-based study. Int J Radiat Oncol Biol Phys 73:15-23, 2009. PMCID: PMC2742208


Zhou L, Luo L, Qi X, Li X, Gorodeski GI. Regulation of P2X(7) gene transcription. Purinergic Signal 5:409-426, 2009. PMCID: PMC2717324


Zhou M, Kort E, Hoekstra P, Westphal M, Magi-Galluzzi C, Sercia L, Lane B, Rini BBukowski R, Teh BT. Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: molecular and histologic evidence. Am J Surg Pathol 33:72-80, 2009.


Zhou M, Reuther AM, Levin HS, Falzarano SM, Kodjoe E, Myles J, Klein E, Magi-Galluzzi C. Microscopic bladder neck involvement by prostate carcinoma in radical prostatectomy specimens is not a significant independent prognostic factor. Mod Pathol 22:385-392, 2009.


Zhou M, Yang XJ, Lopez JI, Shah RB, Hes O, Shen SS, Li R, Yang Y, Lin F, Elson P, Sercia L, Magi-Galluzzi C, Tubbs R. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: Implications for pathologic classification. Am J Surg Pathol 33:1840-1849, 2009.


Zhu J, Tang C, Kottke-Marchant K, Marchant RE. Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptides. Bioconjug Chem 20:333-339, 2009. PMCID: PMC2706486


Zhu S, Gladson CL, White K, Ding Q, Stewart J Jr., Jin T, Chapman H, Olman MA. Urokinase receptor mediates lung fibroblast attachment and migration towards provisional matrix proteins through Interaction with multiple integrins. Am J Physiol Lung Cell Mol Physiol 297:L97-108, 2009. PMCID: 2711805


Zhu X, Gallogly MM, Mieyal JJ, Anderson VE, Sayre LM. Covalent cross-linking of glutathione and carnosine to proteins by 4-oxo-2-nonenal. Chem Res Toxicol 22:1050-1059, 2009.


Zhukovsky DS, Hwang JP, Palmer JL, Willey J, Flamm AL, Smith ML. Wide variation in content of inpatient do-not-resuscitate order forms used at National Cancer Institute-designated cancer centers in the United States. Support Care Cancer 17:109-115, 2009.


Zorn KK, Tian C, McGuire WP, Hoskins WJ, Markman M, Muggia FM, Rose PG, Ozols RF, Spriggs D, Armstrong DK. The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study. Cancer 115:1028-1035, 2009. .PMCID: 2664510